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We conducted a controlled before-and-after trial to evaluate the impact of an onsite urban 38 
sanitation intervention on the prevalence of enteric infection, soil transmitted helminth re-39 
infection, and diarrhea among children in Maputo, Mozambique. A non-governmental 40 
organization replaced existing poor-quality latrines with pour-flush toilets with septic tanks 41 
serving household clusters. We enrolled children aged 1-48 months at baseline and measured 42 
outcomes before and 12 and 24 months after the intervention, with concurrent measurement 43 
among children in a comparable control arm. Despite nearly exclusive use, we found no evidence 44 
that intervention affected the prevalence of any measured outcome after 12 or 24 months of 45 
exposure. Among children born into study sites after intervention, we observed a reduced 46 
prevalence of Trichuris and Shigella infection relative to the same age group at baseline (<2 47 
years old). Protection from birth may be important to reduce exposure to and infection with 48 
enteric pathogens in this setting. 49 
Introduction 50 
Rapid urbanization has led to the expansion of informal settlements in many low- and middle-51 
income countries (LMICs). Such settlements often have very limited sanitation infrastructure 52 
(UN-Habitat, 2016). Separation of human waste from human contact can prevent exposure to 53 
enteric pathogens that cause infection, diarrhea (Liu et al., 2016), and potentially long-term 54 
health effects such as environmental enteric dysfunction (EED) (Kosek et al., 2017), linear 55 
growth deficits (Rogawski et al., 2018), impaired cognitive development (MAL-ED Network 56 
Investigators, 2018),  and reduced oral vaccine immunogenicity (Parker et al., 2018). Children 57 
living in densely populated slum areas where fecal contamination is pervasive and sanitation 58 
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infrastructure is limited may be at an increased risk of adverse health effects due to frequent 59 
exposure to enteric pathogens (Ezeh et al., 2017; Fink, Günther, & Hill, 2014).  60 
Household-level sewerage has demonstrated health benefits (Barreto et al., 2010, 2007; Norman, 61 
Pedley, & Takkouche, 2010) and remains an important long-term goal for many urban settings 62 
despite limited evidence from controlled trials (Norman et al., 2010; Wolf et al., 2018). Such 63 
systems may not be feasible short-term solutions due to cost, space, and logistical constraints, 64 
challenges that have also impeded their evaluation via randomized trials (Norman et al., 2010). 65 
Further, in densely populated areas, there may not be space for household-level sanitation of any 66 
type. Shared sanitation is a subject of considerable debate but may represent the only near-term 67 
sanitation option in some settings (Evans et al., 2017; Heijnen et al., 2014; Tidwell et al., 2020). 68 
Yet, while shared, onsite systems may fill the growing need for safe sanitation in rapidly 69 
expanding urban areas in LMICs, to date, there has been little evidence of their health impacts in 70 
these settings. Recent large-scale, rigorous evaluations of onsite sanitation interventions and 71 
combined water, sanitation, and hygiene interventions have demonstrated mixed effects on 72 
health (Clasen et al., 2014; Humphrey et al., 2019; Luby et al., 2018; Null et al., 2018; Patil et 73 
al., 2014; Pickering, Djebbari, Lopez, Coulibaly, & Alzua, 2015) but all were conducted in rural 74 
areas with household-level interventions, and their findings may have limited generalizability to 75 
urban areas. A recent meta-analysis estimated that non-sewered interventions reduced the risk of 76 
self-reported diarrhea by 16% but did not estimate effects on objective health outcomes, such as 77 
enteric infection (Brown & Cumming, 2019), and could not stratify estimates by rural versus 78 
urban setting given the lack of evidence in urban areas (Wolf et al., 2018). To-date, no controlled 79 
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trials of urban onsite sanitation have been conducted despite over 740 million urban residents 80 
relying on such technologies (Berendes, Sumner, & Brown, 2017).  81 
The Maputo Sanitation (MapSan) trial was the first controlled trial to evaluate an onsite, shared 82 
sanitation intervention in an urban setting and the first to use the prevalence of enteric infection, 83 
as detected by molecular methods, as the primary study outcome (Brown et al., 2015). The study 84 
was located in densely populated, low-income, informal neighborhoods of Maputo, Mozambique 85 
where the sanitary conditions are poor and disease burden high (Knee et al., 2018). As of 2017, 86 
only half of urban residents in Mozambique had access to at least basic sanitation infrastructure, 87 
3% had access to sewerage, and 9% shared sanitation with multiple households, often in poor 88 
neighborhoods where space and resources are limited (UNICEF/WHO, 2019). We investigated 89 
whether an engineered, onsite, shared sanitation intervention could reduce enteric infection and 90 
diarrhea in young children living in these low-income, densely populated neighborhoods in 91 
Maputo, Mozambique.  92 
Results  93 
The MapSan trial was a controlled before-and-after trial designed to evaluate the impact of an 94 
onsite sanitation intervention on child health after 12 and 24 months of follow-up. The 95 
intervention consisted of pour-flush toilets to septic tanks with soakaway pits to discharge the 96 
liquid portion of the waste. A non-governmental organization (NGO) delivered the intervention 97 
to clusters of households known as compounds, replacing the existing poor-condition shared 98 
facilities. Control compounds did not receive the intervention and continued to use their poor-99 
condition sanitation for the duration of the study. We assessed several measures of child health, 100 
including enteric infection measured via stool-based molecular methods, soil-transmitted 101 
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helminth (STH) re-infection measured via Kato-Katz, and diarrhea measured via caregiver report 102 
in both intervention and control children during three phases: baseline (pre-intervention), 12-103 
month follow-up, and 24-month follow-up. Children were eligible for baseline enrollment if they 104 
were less than four years old (1-48 months old). At follow-up, children were eligible for 105 
enrollment if they were less than four years old or if they would have been less than four years 106 
old during baseline.  107 
We enrolled 987 children in 495 compounds during the baseline phase (February 2015 – 108 
February 2016) and collected stool samples (whole stool or diaper samples containing liquid 109 
diarrhea) from 765 children (78%) (Figure 1). During the 12-month follow-up phase (March 110 
2016 – April 2017), we enrolled or revisited 939 children in 438 compounds and collected 805 111 
stool samples (86%). During the 24-month follow-up phase (April 2017 – August 2018), we 112 
enrolled or revisited 1001 children in 408 compounds and collected stool samples from 922 113 
(90%). To improve the success rate of stool sample collection during the 12- and 24-month 114 
follow-up visits, we collected rectal swabs from children who did not provide a whole stool 115 
sample after multiple collection attempts. The proportion of each type of sample (whole stool, 116 
diaper sample, and rectal swab) was similar between arms at each phase (Appendix 1-figure 1). 117 
Fewer than 5% of all samples were diapers and approximately 7% of 12-month samples and 25% 118 
of 24-month samples were rectal swabs (Appendix 1-table 1). The NGO delivered interventions 119 
to 15 control compounds after baseline and children in those compounds were censored at the 120 
time of intervention receipt (Figure 1). Children living in control compounds that independently 121 
upgraded their latrines were included in the main analyses. However, as inclusion of these 122 
control children may have diluted the intervention effect, they were excluded from sensitivity 123 
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analyses designed to understand the impact of the intervention when compared with controls 124 
with poor-condition sanitation throughout the study. Children in intervention and control 125 
compounds were enrolled at similar rates during each phase ( Appendix 1-figure 2). Due to 126 
migration out of the compound, we collected longitudinal data from 62% of children (59% 127 
controls, 67% interventions) between baseline and 12-month and 51% of children (46% controls, 128 
58% interventions) between baseline and 24-month. 129 
At baseline enrollment, intervention compounds had more residents, households, and on-premise 130 
water taps than controls, though the number of shared latrines was similar (Table 1). Animals 131 
were observed in over half of all compounds. Intervention and control households had similar 132 
wealth scores, though intervention households had more members and were more crowded while 133 
control households more often had walls made of sturdy materials. All households used a 134 
municipal water tap as their primary drinking water source with 78% reporting use of a tap on 135 
the compound grounds. At baseline, latrines used by intervention households more often had 136 
pedestals or slabs, drop-hole covers, and sturdy walls compared with controls. Consistent with 137 
previous estimates in urban Maputo (Satterthwaite, Beard, Mitlin, & Du, 2019), open defecation 138 
was rare in our study population with only one control household reporting open defecation at 139 
baseline. Baseline characteristics of intervention and control children were similar: the average 140 
age at enrollment was 23 months (SD = 13), 51% were female, and 32% were still breastfeeding 141 
(Table 1). The age distributions of intervention and control children were similar at baseline and 142 
both follow-up phases (Appendix 1-figure 3). 143 
We used the Luminex Gastrointestinal Pathogen Panel (GPP), a qualitative multiplex molecular 144 
assay, to simultaneously test for 15 enteric pathogens in stool samples, including nine bacteria, 145 
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three protozoa, and three viruses.  We detected ≥1 bacterial or protozoan enteric infection, our 146 
pre-defined primary outcome, in 78% (591/753) of children with stools available at baseline. We 147 
measured our pre-defined secondary outcome, ≥1 STH re-infection, using the Kato-Katz 148 
microscope method and detected ≥1 STH in 45% (308/698) of stools at baseline. The 149 
prevalences of pre-defined outcomes, individual pathogens, and pathogen types were similar 150 
between the intervention and control arms at baseline (Table 2). The prevalence of most 151 
bacterial, protozoan, and STH infections increased with age while the prevalence of enteric 152 
viruses decreased with age (Appendix 1-table 2 and Appendix 1-figure 4).   153 
The characteristics of children with repeated observations (including baseline) were similar to 154 
characteristics of children measured at baseline only (Appendix 1-table 3 and Appendix 1-table 155 
4) and to characteristics of children measured at 12-month and/or 24-month only with the 156 
exception of age-related characteristics (Appendix 1-table 5 and Appendix 1-table 6). Over half 157 
of the children enrolled after baseline were born into study sites (336/622 [54%], Figure 1).  158 
Our main analyses included observations from all eligible children enrolled at baseline (mean 159 
sampling age 664 days, SD=393) and the 12-month (940 days, SD=498) and 24-month (1137 160 
days, SD=603) follow-up visits (Table 2). We used a difference-in-difference (DID) analysis to 161 
estimate the intervention effect and adjust for baseline differences between intervention and 162 
control compounds. We present effect estimates from the DID analyses as prevalence ratios 163 
(ratio of ratios).  To assess the validity of the parallel trend assumption, a key assumption of DID 164 
analyses, we ran “placebo tests” by replacing outcomes with variables unrelated to the 165 
intervention, such as child age, respondent role, and presence of animals. Placebo tests showed 166 
no effect of the intervention on these variables, suggesting the parallel trend assumption was 167 
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valid. We found no evidence that the intervention had an effect on the prevalence of any 168 
bacterial or protozoan infection (adjusted PR 1.04, 95% CI [0.94 – 1.15]), or any STH re-169 
infection (1.11 [0.89 – 1.38]) 12 months after implementation (Table 2) despite household 170 
respondents reporting almost exclusive use of the intervention latrine (97%, 404/417). The 171 
prevalence of diarrhea remained fairly constant in both arms in all three phases with the 172 
exception of the 12-month measure in the control arm which was lower, resulting in a larger 173 
effect estimate with low precision (1.69 [0.89-3.21]). 174 
The intervention had no meaningful effect at 12 months on the prevalence of infection with any 175 
of the three pathogen types measured by the GPP (bacterial, protozoan, viral), pathogen 176 
coinfection, or on any individual pathogen (Table 2). There was poor precision in the effect 177 
estimates for infrequently detected pathogens, evident from their wide confidence intervals. 178 
Therefore, some estimates suggestive of a large protective or detrimental effect (Campylobacter, 179 
C. difficile, E. coli O157, STEC, Norovirus GI/GII, Adenovirus 40/41) may have arisen by 180 
chance. While the National Deworming Campaign (NDC) provided albendazole to all compound 181 
members following baseline, during 12-month visitation only 58% of caregivers (56% control, 182 
60% intervention) confirmed that their child was dewormed during these visits. A sensitivity 183 
analysis restricted to children confirmed to have been dewormed produced similar results to the 184 
main analysis (Appendix 1-table 7). By the 12-month visit, 19 control compounds (19/240 185 
[8.0%]) had independently upgraded their facilities to pour-flush toilets. Results from sensitivity 186 
analyses excluding children living in control compounds with independently upgraded facilities 187 
were consistent with the main results (Appendix 1-table 8). 188 
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There was no evidence that the intervention had an effect on the prevalence of any bacterial or 189 
protozoan infection, any STH re-infection, or diarrhea after 24 months among all enrolled 190 
children (Table 2). We also found limited evidence of effect on the prevalence of any pathogen 191 
type or coinfection with ≥2 GPP pathogens 24 months after intervention. Results for several 192 
individual outcomes were suggestive of a protective (STEC, E. coli O157, Cryptosporidium, 193 
STH coinfection) or adverse (Campylobacter, C. difficile) effect, but evidence was weak as 194 
estimates were accompanied by wide confidence intervals and chance discoveries were possible 195 
given multiple comparisons. At the 24-month visits, caregivers confirmed baseline and/or 12-196 
month deworming more frequently for intervention children (339/502 [68%]) than for control 197 
children (286/499 [57%]). Adjustment for deworming status or time since deworming had no 198 
impact on effect estimates ( Appendix 1-table 7). Excluding children from control compounds 199 
which independently upgraded their facilities by the 24-month visit (35/211 compounds, [17%]) 200 
did not impact the results (Appendix 1-table 8). 201 
Point estimates of effect and associated confidence intervals were largely similar in unadjusted 202 
and adjusted models with few exceptions (e.g. ETEC at 24-month) (Table 2). Multivariable 203 
models for GPP outcomes and STH outcomes were adjusted for covariates selected a priori 204 
(child age, sex, caregiver education, and household wealth index). No other variables met our 205 
inclusion criteria for multivariable models, which included being imbalanced between 206 
intervention and control at baseline and meaningfully changing 12-month effect estimates (>10% 207 
change in prevalence ratios) (Appendix 1-table 9). While the relationship between age and 208 
pathogen prevalence appeared to be non-linear for many pathogens (Appendix 1-figure 4), the 209 
inclusion of a higher order age term (age squared) did not meaningfully change effect estimates 210 
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in the main or sub-group analyses (Appendix 1-table 10). Three measures of seasonality were 211 
considered for inclusion in multivariable models to adjust for any difference in seasonal 212 
distributions of data collection: (1) a binary variable defining the ‘rainy’ (November – April) and 213 
‘dry’ seasons (May – October) in Maputo, (2) a measure of cumulative rainfall (mm) in the 30 214 
days prior to data collection, and (3) sine and cosine terms representing dates of sample 215 
collection. While there was some imbalance between arms in data collected during the wet and 216 
dry seasons at baseline (Appendix 1-table 9), no measure of seasonality meaningfully changed 217 
effect estimates in the 12- and 24-month analyses and seasonality was excluded from final 218 
multivariable models (Appendix 1-table 9 and Appendix 1-table 11). For diarrhea, two variables 219 
in addition to variables selected a priori met our inclusion criteria and were included in adjusted 220 
models: presence of a latrine drop-hole cover at baseline and reported use of a water tap located 221 
within the compound grounds at baseline (Appendix 1-table 9). The magnitude of effect 222 
estimates were larger and confidence intervals wider for diarrhea in adjusted versus unadjusted 223 
models in the 12-month and 24-month analyses (Table 2). In addition to the main analyses which 224 
included all enrolled children, we also performed two sub-group analyses. The first included 225 
children who were born after the intervention was implemented (or after baseline in control 226 
compounds) and present at the 12- and/or 24-month follow-up visit. This analysis allowed us to 227 
evaluate the impact of the intervention on young children who were never exposed to the poor 228 
sanitation at baseline. The second sub-group analysis included only children with repeated 229 
measures at baseline and 12- and/or 24-month follow-up. 230 
In sub-group analyses comparing children born into study compounds before the 24-month visit 231 
with children of similar ages at baseline (<2 years old), there was suggestive evidence that the 232 
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intervention reduced the prevalence of infection with any STH by half (n=522; adjusted 233 
prevalence ratio 0.51, [95% CI 0.27 - 0.95]), Trichuris by 76% (n=522; 0.24, [0.10 - 0.60]), and 234 
Shigella by 51% (n=630; 0.49, [0.28 - 0.85]) (Table 3). These effects were attenuated in sub-235 
group analyses restricted to older children (>24 months) who were born before the intervention 236 
was implemented and present at the 24-month phase (Appendix 1-table 12). We did not observe 237 
intervention effects among children born into the study by the 12-month visit, but the sample size 238 
was small, resulting in high uncertainty in effect estimates (Appendix 1-table 13).  239 
Longitudinal sub-group analyses explored the effect of the intervention on children with repeated 240 
measures at baseline and 12-month (for unadjusted analyses: n=870 data points [435 children 241 
with repeat measures] for GPP outcomes, n=572 [286] for Kato-Katz outcomes, and n=1112 242 
[556] for diarrhea) and at baseline and 24-month (n=716 (358), n=402 (201), n=834 (417)). 243 
Effect estimates were consistent with results from the main analyses (Appendix 1-table 14 and 244 




We found no evidence that this urban, onsite shared sanitation intervention was protective 247 
against our pre-specified child health outcomes of enteric infection, STH re-infection, or 248 
diarrhea. We also found no strong evidence that the intervention affected prevalence of any 249 
individual pathogen, pathogen type, or coinfection with ≥2 enteric pathogens or STH. In 250 
exploratory sub-group analyses, we found suggestive evidence that the intervention reduced the 251 
prevalence of any STH, Trichuris, and Shigella infections among children born into the study by 252 
the 24-month follow-up visit. Studying children born into intervention sites after implementation 253 
allowed us to examine the effect of the intervention from birth through the first two years of life. 254 
These results suggest that the intervention delayed pathogen exposure and the accumulation of 255 
enteric infections during early childhood, but it needs to be treated with caution as this was an 256 
exploratory subgroup analysis.  257 
The trial was neither designed nor powered to detect differences in sub-groups of children such 258 
as those born after the intervention was implemented, potentially limiting our ability to detect 259 
small effects in such analyses. Further, all exploratory sub-group analyses included multiple 260 
comparisons, increasing the likelihood of chance discoveries. However, the magnitude of the 261 
effect estimates for the outcomes of any STH, Trichuris, and Shigella observed among children 262 
born into the study by the 24-month visit, and the directional consistency of effect estimates 263 
among most other outcomes in this sub-group analysis, strengthens the plausibility of these 264 
findings. 265 
There are several reasons we observed suggestive evidence of an effect for some outcomes 266 
among this sub-group of young children but not among older children or in the main analyses. 267 
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Children’s exposures vary by age, particularly as they become mobile and begin independent 268 
exploration of their environment. It is possible that the intervention reduced exposure via 269 
pathways that are important for very young children but may represent just minor pathways of 270 
exposure among older children (Kwong et al., 2020) Additionally, young children may 271 
experience fewer exposures outside of the compound. Reductions in exposure and subsequent 272 
infection early in life may delay or prevent the development of environmental enteric 273 
dysfunction (EED), a subclinical condition that affects the structure and function of the gut and 274 
may increase susceptibility to future infection (Keusch et al., 2014; Prendergast & Kelly, 2016). 275 
Results from the EED sub-study of the WASH Benefits cluster randomized controlled trial 276 
(cRCT) in Bangladesh suggest that the intervention delayed but did not prevent the onset of EED 277 
(Lin et al., 2019). If this intervention similarly delayed the development of EED among children 278 
born into intervention sites, they may have been less susceptible to infection than children of a 279 
similar age at baseline.  Finally, some pathogens, like Giardia and certain STH, can cause 280 
persistent infections that can remain active for months or years if not treated (Else et al., 2020; 281 
Rogawski et al., 2017). The intervention would have no effect on such infections, highlighting 282 
the potentially important role of protection from birth.  283 
Notably, both Shigella and Trichuris are primarily anthroponotic, and infection was strongly age-284 
dependent in this study population (Knee et al., 2018). These factors may help explain the 285 
differing intervention effects observed both among pathogens and age groups. The intervention 286 
was unlikely to limit exposure to animal feces, reducing the likelihood that it would impact 287 
infection prevalence of zoonotic pathogens like Campylobacter or Giardia. The strong positive 288 
associations between age and prevalence for Shigella and Trichuris suggest that exposure 289 
15 
 
increases with age. This supports the hypothesis that the intervention may have reduced the 290 
overall frequency or intensity of exposure enough to impact Shigella and Trichuris infection 291 
among young children but not older children.  292 
Rapid urbanization is expanding informal settlements and out-pacing the expansion of sanitation 293 
services in many cities, widening the gap in sanitation access between the urban rich and poor 294 
(UNICEF/WHO, 2019). To our knowledge, MapSan was the first trial to estimate the health 295 
impact of an urban, onsite shared sanitation intervention and the first to use enteric infection as 296 
the primary trial outcome. Most of the urban sanitation literature published to date has evaluated 297 
the expansion of sewerage, an important and ambitious goal that is out of reach for many cities in 298 
the near-term  (Norman et al., 2010). Access to sewerage is associated with a 30-60% reduction 299 
of diarrheal disease depending on starting conditions, and an approximately 30% reduction in 300 
enteric parasite detection, though most studies are observational and few controlled trials exist 301 
(Barreto et al., 2010; Norman et al., 2010; Wolf et al., 2018).  302 
Most studies of onsite sanitation interventions have occurred in rural areas. Despite good 303 
evidence that onsite sanitation is associated with reductions in diarrheal disease (M. C. Freeman 304 
et al., 2017; Wolf et al., 2018), several recent rural trials of basic sanitation and combined 305 
WASH  interventions with good uptake and use reported mixed effects on child health outcomes 306 
including diarrhea, linear growth, and more recently, enteric infection (Ercumen et al., 2019; 307 
Grembi et al., 2020; Humphrey et al., 2019; Lin et al., 2018; Luby et al., 2018; Null et al., 2018; 308 
Pickering et al., 2019; Rogawski McQuade, Platts-Mills, et al., 2020).  309 
The Sanitation, Hygiene, Infant Nutrition Efficacy (SHINE) trial in rural Zimbabwe found no 310 
impact of a combined WASH intervention on diarrhea, growth, or the prevalence of a suite of 311 
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enteric pathogens among children aged <12 months old but did report a small reduction in the 312 
number of parasitic pathogens detected.(Humphrey et al., 2019; Rogawski McQuade, Platts-313 
Mills, et al., 2020)  314 
While the WASH Benefits Bangladesh cRCT reported no effect of any WASH intervention on 315 
child growth, the sanitation, hygiene, and combined WASH study arms reduced the prevalence 316 
of diarrheal disease from 5.7% to 3.5% (Luby et al., 2018), accompanied by absolute reductions 317 
in Giardia prevalence of 6-9% among children aged 2-3 years in the same arms (Lin et al., 318 
2018). The sanitation arm also reduced the prevalence of T. trichiura among children 2-3 years 319 
old (from 5.2% to 3.2%) but had no impact on A. lumbricoides or hookworm, the only other 320 
parasites detected frequently enough to estimate effects in that study (Ercumen et al., 2019). In a 321 
parallel analysis, only the water treatment and combined WASH interventions of the WASH 322 
Benefits Kenya cRCT reduced the prevalence A. lumbricoides, suggesting that the reduction in 323 
prevalence in the combined WASH arm may be attributable to the water treatment intervention 324 
(Pickering et al., 2019). The sanitation-only arm had no impact on any parasite measured, though 325 
T. trichiura was too infrequently detected to estimate effects (Pickering et al., 2019). An 326 
evaluation of a comprehensive suite of 34 enteric pathogens reported reduced prevalence and 327 
quantity of enteric viruses, but not bacteria or parasites, among children aged 14 months old in 328 
the combined WASH arms in the Bangladesh trial (Grembi et al., 2020). Together with our 329 
findings, these results suggest that sanitation and combined WASH interventions can reduce the 330 
prevalence of enteric infection in some settings but that effects may vary by pathogen, child age, 331 
intervention, and setting.  332 
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We previously published two baseline risk factor analyses to identify demographic, 333 
environmental, and WASH-related predictors of infection and environmental fecal contamination 334 
in our study setting prior to the intervention implementation (Holcomb et al., 2020; Knee et al., 335 
2018). Age was an important predictor of infection, though the direction of its effect varied by 336 
pathogen type. Increasing age was associated with increased risk of bacterial and protozoan 337 
infections and decreased risk of viral infections (Knee et al., 2018). Other socio-demographic 338 
predictors of infection included breastfeeding, which was associated with a decreased risk of any 339 
infection (driven by its strong association with protozoan infection), and female sex which was 340 
associated with an increased risk of viral infection. Few sanitation-related or environmental 341 
variables were associated with infection at baseline and the magnitude of associations were often 342 
small. The presence of a latrine superstructure and drop-hole cover were associated with small 343 
reductions in risk of bacterial or protozoan infection, often only in unadjusted analyses, but other 344 
latrine features (e.g. presence of a cleanable slab) were not. The observation of feces or used 345 
diapers around the compound grounds was associated with increased risk of bacterial and 346 
protozoan infection but most other environmental and sanitary hazards were not (Knee et al., 347 
2018).  348 
Fecal contamination was common among all environmental reservoirs tested (water, soil, food 349 
preparation surfaces) at baseline. We detected one or more microbial markers of contamination 350 
in over 95% of environmental samples (Holcomb et al., 2020). E. coli was the most frequently 351 
detected and abundant marker of contamination among all sample types, and human-associated 352 
markers were most frequently detected in soil (59%) and stored drinking water (17%) samples. 353 
Measures of latrine quality that were associated with small reductions in infection risk (e.g. drop-354 
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hole covers, latrine superstructures) were not associated with decreased odds of fecal 355 
contamination in this setting. Overall, we found few consistent relationships between markers of 356 
fecal contamination and environmental, WASH-related, and demographic characteristics at 357 
baseline (Holcomb et al., 2020).  358 
While these results suggest WASH-related and environmental risk factors may be poor 359 
determinants of child health in this setting, the lack of heterogeneity in WASH conditions at 360 
baseline, given the selection criterion that compounds must share sanitation in “poor condition,” 361 
may have limited our ability to identify strong WASH-related predictors of infection or 362 
environmental fecal contamination. Results from a forthcoming companion study suggests the 363 
intervention had mixed effects on environmental fecal contamination. The intervention may have 364 
reduced the concentration of E. coli by an order of magnitude in soil collected from latrine 365 
entrances after 12 months, however, there was no effect on the prevalence or concentration of 366 
indicators of fecal contamination in any other environmental compartment sampled at that time 367 
(Holcomb et al., 2021).  It is unlikely that the observed reductions in fecal contamination in soils 368 
alone would be sufficient to impact health outcomes in this setting. Other studies that have 369 
evaluated the impact of sanitation interventions on fecal contamination of the surrounding 370 
environment have found limited evidence of effect (Clasen et al., 2014; Ercumen, Mertens, et al., 371 
2018; Ercumen, Pickering, et al., 2018; Fuhrmeister et al., 2020; Patil et al., 2014; Pickering et 372 
al., 2015; Gloria D. Sclar et al., 2016; Steinbaum et al., 2019).  373 
In this setting, where fecal contamination was pervasive and burden of infection high, even 374 
considerable reductions in contamination and exposure may have been insufficient to realize 375 
measurable health gains as the intervention did not address all potential transmission pathways 376 
19 
 
(Briscoe, 1984; Julian, 2016; Robb et al., 2017). For example, the intervention did not address 377 
child feces disposal practices or handwashing behaviors and it is unlikely that the intervention 378 
infrastructure would have changed these (Majorin, Torondel, Chan, & Clasen, 2019). Previous 379 
studies of sanitation interventions have found no reduction in hand contamination (Ercumen, 380 
Pickering, et al., 2018), which has been associated with increased incident diarrheal disease in 381 
young children (Pickering et al., 2018). The intervention may not have reduced exposure via 382 
consumption of contaminated food – particularly foods contaminated prior to arrival in the 383 
compound – likely an important source of enteric pathogen transmission in some settings (Julian, 384 
2016; Kwong et al., 2020). Children’s exposure to animal feces has been documented in rural, 385 
peri-urban, and urban settings and could be an important, unmitigated source of exposure to 386 
enteric pathogens in both intervention and control arms where animals were frequently observed 387 
(Delahoy et al., 2018; Kwong et al., 2020; Penakalapati et al., 2017). Observation of animals in 388 
compounds was examined as a potential confounder but did not change effect estimates. 389 
The intervention was delivered at the compound level, not the community level, and was not 390 
designed to achieve any specified threshold of sanitation coverage in the study neighborhoods. 391 
Previous studies have suggested that achieving a certain level of community sanitation coverage 392 
may be necessary to reduce disease burdens (Barreto et al., 2007; Fuller & Eisenberg, 2016; 393 
Fuller, Villamor, Cevallos, Trostle, & Eisenberg, 2016; Harris, Alzua, Osbert, & Pickering, 394 
2017; Jung, Lou, & Cheng, 2017; Spears, Ghosh, & Cumming, 2013; Wolf et al., 2018). For 395 
example, a study of a large-scale sewerage expansion in urban Brazil found that the intervention 396 
reduced diarrheal disease by 22%, with neighborhood coverage level being the single most 397 
important explanatory variable (Barreto et al., 2007).  We did not measure neighborhood-level 398 
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sanitation coverage, but previous estimates show that while coverage is high and open defecation 399 
is limited (1%), only 9% of sanitation systems are safely managed (Satterthwaite et al., 2019). 400 
Further, in the Nhlamankulu district where many of our study sites are located, the majority of 401 
households (56%) rely on pit latrines serving individual households, most of which are in poor 402 
condition (Devamani, Norman, & Schmidt, 2014; Satterthwaite et al., 2019). Together with our 403 
results, this suggests that both the extent and quality of community coverage are likely important 404 
to reducing overall transmission. Sanitation coverage and quality may be especially important in 405 
urban areas given the proximity of compounds and the opportunity for person-to-person contact, 406 
neighborhood-level exposure, and for external sources of contamination (e.g. a neighbor’s 407 
flooded pit latrine) to influence compound-level exposures (Barreto et al., 2007). We did not 408 
measure neighborhood-level exposures, which may be important for young children in slum 409 
settings (Ezeh et al., 2017; Medgyesi et al., 2019), and their impact on our health outcomes is 410 
unclear. In addition to neighborhood-level exposures, the transience of the study population 411 
meant that trips to and from provinces outside of Maputo, where exposures were varied and 412 
unmeasured, were common.  413 
It is unlikely that our findings are due to poor intervention fidelity or use, a challenge 414 
encountered in some trials of rural sanitation interventions (Clasen et al., 2014; Patil et al., 2014). 415 
The use of the intervention required minimal behavior change as compound members switched 416 
from using their existing latrine in poor condition, which was removed following construction of 417 
the intervention latrine, to using the new hygienic latrine. The results of a forthcoming process 418 
evaluation demonstrate that 96% of intervention latrines were well-maintained two or more years 419 
after construction, suggesting continued use by compound members (Bick et al., 2021). Further, 420 
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only 3% of intervention compounds (8/270) had a secondary, non-intervention latrine in use after 421 
two or more years, indicating that members of most intervention compounds exclusively used the 422 
intervention latrines  (Bick et al., 2021). It is possible that development in the study 423 
neighborhoods, including changes to sanitation facilities in control compounds, contributed to 424 
the limited effect of the intervention. However, results from sensitivity analyses that excluded 425 
control compounds with upgraded sanitation were consistent with results from the main analyses.  426 
The two intervention designs we evaluated in this study – communal sanitation blocks and 427 
shared latrines – utilized the same basic sanitation technology but differed in the number of 428 
cabins and amenities available. While it is possible that this heterogeneity in design may have 429 
modified the effect of the intervention, this study was not powered to test this. Moreover, all 430 
intervention compounds were encouraged to independently upgrade their facilities by adding 431 
features like electricity and handwashing stations, or by connecting existing handwashing 432 
stations to the water supply, resulting in heterogeneity even within the two broad categories of 433 
intervention type.  434 
While the NDC dewormed every study compound annually during the study period, it is possible 435 
that not all study participants received, or took, the medication and that the time between 436 
deworming and subsequent measurement of STH re-infection varied among children. 437 
Additionally, single-dose albendazole can have limited effectiveness against certain STH, 438 
notably Trichuris (Moser, Schindler, & Keiser, 2017). Inadequate or ineffective deworming 439 
could have limited our ability to detect an effect on STH outcomes. Sensitivity analyses 440 
adjusting for caregiver-confirmed deworming and for estimated time between deworming and re-441 
infection measurement produced similar results to the main analysis.  442 
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There are several important limitations of this study. As the intervention was pre-planned and not 443 
implemented by the study team, we could not randomize its allocation, increasing the risk of 444 
confounding. We assessed potential confounding variables at baseline and used a DID analysis, 445 
which accounts for baseline outcome measures, to limit the effect of unmeasured, residual 446 
confounding. While we attempted to enroll intervention and control compounds with comparable 447 
numbers of residents, the NGO which identified and implemented the intervention selected most 448 
of the largest eligible compounds for intervention. This resulted in intervention compounds 449 
having a slightly higher mean number of residents than control compounds (Table 1). Crowding 450 
has been identified as a risk factor for pathogen transmission and poor health outcomes in other 451 
studies, (Halpenny, Koski, Valdés, & Scott, 2012; Rahman, Wojtyniak, Mujibur Rahaman, & 452 
Aziz, 1985; Rogawski McQuade, Shaheen, et al., 2020) though we found limited evidence of this 453 
in our study population at baseline (Knee et al., 2018). Further, we assessed the number of 454 
compound residents as a potential confounder but found that it did not meaningfully change the 455 
DID estimates for our pre-defined outcomes (Appendix 1-table 9). We consider our analysis to 456 
be robust to small differences in study arms at baseline, however, we cannot exclude the 457 
possibility of residual confounding due to such differences, a limitation of non-randomized 458 
designs.  459 
It was not possible to mask participants to their intervention status, and our measure of caregiver-460 
reported diarrhea could be subject to respondent and recall biases. To reduce the risk of 461 
respondent bias, the MapSan field enumerator team and implementation team were different, and 462 
respondents were not informed explicitly that the MapSan team was evaluating the health effect 463 
of the intervention. To limit recall bias, we used a 7-day recall period (Arnold et al., 2013). Our 464 
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other pre-specified outcomes were objective measures of pathogen infection and not subject to 465 
the same biases (Brown & Cumming, 2019).  466 
Due to the greater than expected losses to follow-up in both study arms, we were not able to 467 
follow all children enrolled at baseline through time as expected, but we still achieved our target 468 
enrollment numbers due to migration and births into study compounds. We conducted the 469 
originally planned longitudinal analysis as a sub-group analysis. It also served as a sensitivity 470 
analysis to estimate the impact of migration on our effect estimates. Results from this sub-group 471 
analysis were largely similar to results of the main analysis which treated measures as repeated 472 
cross-sections, though the reduction in sample size led to wider confidence intervals (Appendix 473 
1-table 14 and Appendix 1-table 15). Measures of outcomes and covariates in children with and 474 
without repeated measures were mostly similar, further limiting the likelihood that changes in the 475 
study population biased our results.  476 
While molecular detection of enteric pathogens in stool is evidence of pathogen exposure, it is 477 
not necessarily evidence of active infection, making its clinical significance less clear (Brown & 478 
Cumming, 2019). We assumed pathogen detection by the GPP indicated infection because the 479 
assay’s limits of detection exceeded the median infectious dose of most pathogens. While the 480 
GPP detects many enteric pathogens recognized as important causes of childhood diarrhea in 481 
LMICs, (Liu et al., 2016) it does not detect all enteric pathogens of importance. Further, 482 
qualitative, cross-sectional analysis of stools does not provide information on the duration or 483 
intensity of infection or pathogen carriage. Quantitative results, like those produced by multiplex 484 
quantitative PCR panels, can be used to aid identification of etiologic agents of diarrhea, 485 
especially in cases of coinfection, and to differentiate between low-level enteric pathogen 486 
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detection of unknown clinical relevance and higher concentration shedding which is more clearly 487 
associated with disease (Liu et al., 2014, 2016; Platts-Mills, Liu, & Houpt, 2013).  Some studies 488 
have demonstrated overall good performance of the GPP but observed elevated false positive 489 
detection rates for the Salmonella targets (Duong et al., 2016; Kellner et al., 2019). For this 490 
reason, we removed Salmonella results from our pre-specified outcome definition. Results from 491 
analyses including and excluding Salmonella were similar. In addition, some studies have 492 
observed reduced sensitivity or specificity for some GPP targets compared with qPCR-based 493 
methods, including norovirus, adenovirus, Campylobacter, Yersinia enterocolitica, ETEC, and 494 
Salmonella, though inconsistencies between studies exist and are likely due to differences in 495 
comparator assays or sample storage and processing (Chhabra et al., 2017; Deng et al., 2015; 496 
Duong et al., 2016; Huang et al., 2016; Zhan et al., 2020; Zhuo et al., 2017). Further, the lack of 497 
an adequate reference standard in most comparative studies complicates interpretation (K. 498 
Freeman et al., 2017).   499 
Our ability to detect an effect on our primary outcome, the prevalence of ≥1 bacterial or 500 
protozoan infection, may have been limited by (1) the extended duration of shedding of some 501 
pathogens following active infection; (2) the overall high burden of disease in our study 502 
population, particularly among older children; and (3) residual confounding by age given the 503 
strong observed relationship between age and infection status (particularly for protozoan 504 
pathogens), all of which may have biased our results toward the null. Further, the intervention 505 
may have impacted the concentration of pathogens shed (Grembi et al., 2020; Lin et al., 2019), 506 
but our binary outcome was not sensitive to such differences  The qualitative nature of the GPP 507 
did not allow us to interrogate this question.   508 
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We analyzed a smaller number of stool samples for STH than for other enteric pathogens due to 509 
requirements of the Kato-Katz method used for STH detection. The Kato-Katz method can only 510 
be performed on whole, solid stool. Diarrheal samples and rectal swabs, the latter of which were 511 
introduced during the 12-month follow-up phase, were not eligible for STH analysis by Kato-512 
Katz. Further, when limited stool material was collected, we prioritized the molecular analysis 513 
used for the primary outcome. While the smaller sample size available for the STH analyses may 514 
have reduced our ability to detect small effects, the proportions of whole stool, diarrheal diaper 515 
samples, and rectal swabs were similar between arms at each phase (Appendix 1-table 1). This 516 
limited the potential impact that sample type could have on our results. 517 
While the Kato-Katz method performs similarly to other microscope-based and molecular 518 
methods for detection of moderate to high intensity infections, it may be less sensitive than 519 
molecular methods in detecting low intensity infections (Benjamin-Chung et al., 2020; Cools et 520 
al., 2019). A recent study has also suggested reduced specificity of the Kato-Katz method for 521 
detection of low-intensity A. lumbricoides infections (Benjamin-Chung et al., 2020). In settings 522 
where low-intensity infections are common, or where STH may be targeted for elimination, 523 
methods with better diagnostic accuracy, like qPCR, may be considered. 524 
We had limited ability to evaluate the impact of seasonality or weather-related trends on our 525 
effect estimates due to drought conditions during the 2015/2016 rainy season. We adjusted 526 
models for cumulative 30-day rainfall, a binary indicator of wet/dry season, and sine/cosine 527 
terms of sample collection date (Stolwijk, Straatman, & Zielhuis, 1999) but excluded all 528 
seasonality terms from final multivariable models because they did not meaningfully change 529 
effect estimates. 530 
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Our results demonstrate that access to hygienic, shared onsite sanitation systems was not 531 
sufficient to reduce enteric infection or diarrhea in children aged 6 years or younger (≤4 at 532 
baseline) 12-24 months after implementation. Results from our sub-group analysis of children 533 
born into intervention sites showed a substantial reduction in the prevalence of any STH, 534 
Trichuris, and Shigella infection, suggesting that children may require protection from birth to 535 
reduce or delay infection burdens. Our results do not suggest that shared sanitation is inadvisable 536 
in this setting, as we did not compare against household-level sanitation improvements, nor do 537 
they account for the many non-health related benefits associated with this intervention or 538 
upgraded sanitation generally (Caruso et al., 2018; G.D. Sclar et al., 2018; Shiras et al., 2018).  539 
The need for effective sanitation solutions may be most urgent in densely populated, low-540 
income, informal communities like our study setting where ubiquitous fecal contamination drives 541 
high infection burdens. Disease transmission in these settings may be driven by multiple 542 
interrelated pathways, complicated by frequent migration and the diversity of circulating 543 
pathogens, and therefore difficult to interrupt. While decades of research have demonstrated 544 
meaningful health gains following sanitation improvements, the results of this study, and other 545 
rigorous trials of sanitation interventions, suggest that the relationship between sanitation and 546 
health is complex, difficult to measure, and may not be generalizable across diverse settings and 547 
populations.  548 
Methods  549 
Study design and intervention  550 
MapSan was a controlled before-and-after trial, and details of the study design and analysis plan 551 
have been published previously (Brown et al., 2015). We conducted the study in 17 densely 552 
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populated, low-income, informal neighborhoods in Maputo, Mozambique. The intervention was 553 
delivered to compounds, typically groups of three to five households (though larger and smaller 554 
compounds exist) often delineated by a wall or barrier, that shared sanitation and outdoor living 555 
space. Shared compound sanitation facilities are not considered public facilities. We collected 556 
data in an open cohort of children in intervention and control compounds at three time-points: 557 
baseline (pre-intervention), 12 months post-intervention, and 24 months post-intervention.  558 
The NGO Water and Sanitation for the Urban Poor selected intervention compounds and 559 
designed and built 300 intervention facilities - pour-flush toilets discharging to septic tanks, the 560 
liquid effluent of which flows to the soil through soakaway pits (Appendix 1-figure 5 and 561 
Appendix 1-figure 6). There were two intervention designs with the same basic sanitation 562 
technology: communal sanitation blocks (CSBs) and shared latrines (SLs) (Appendix 1-figure 7 563 
and Appendix 1-figure 8). The primary difference between CSBs and SLs was size. CSBs (n=50) 564 
included multiple stalls with toilets and served compounds of 21 or more people with one stall 565 
allocated per 20 residents. CSBs also included rainwater harvesting systems, a municipal shared 566 
water connection, elevated water tanks for storage of municipal water, a handwashing basin, a 567 
laundry facility, and a well-drained area for bathing. Shared piped water connections were part of 568 
the municipal water system and could be used for drinking in addition to other domestic 569 
purposes. Rainwater was intended for cleaning and flushing but not drinking. Shared latrines 570 
(n=250) were single-stall facilities serving fewer than 21 people. All septic tanks were sized to 571 
require emptying after approximately two years.  572 
Intervention compounds were located in 11 neighborhoods of the Nhlamankulu and KaMaxakeni 573 
districts of Maputo (Appendix 1-figure 9). The NGO selected intervention compounds using the 574 
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following criteria: (1) residents shared sanitation in poor condition as determined by an engineer; 575 
(2) the compound was located in the pre-defined implementation neighborhoods; (3) there were 576 
no fewer than 12 residents; (4) residents were willing to contribute financially to construction 577 
costs; (5) sufficient space was available for construction of the new facility; (6) the compound 578 
was accessible for transportation of construction materials and tank-emptying activities; (7) the 579 
compound had access to a legal piped water supply; and (8) the groundwater level was deep 580 
enough for construction of a septic tank. Intervention compounds were expected to pay 581 
approximately 10-15% of the construction costs (~$64 for shared latrines and ~$97 for CSBs) 582 
within one year of construction, with 25% of the total due upfront. Presence of a child was not a 583 
selection criterion and therefore not all intervention sites were included in the study. Opening of 584 
newly constructed intervention latrines occurred between February 2015 and February 2016. The 585 
study team used criteria 1, 3, 4, and 7 to select control sites that had at least one child younger 586 
than 48 months old in residence.  We enrolled intervention and control compounds concurrently 587 
to limit any differential effects of seasonality or other secular trends on the outcomes ( Appendix 588 
1-figure 2). Additionally, we attempted to enroll control compounds with similar numbers of 589 
residents as intervention compounds. Willingness to pay for facilities among controls was 590 
assessed using hypothetical versions of questions posed to interventions. Control compounds 591 
were located within the 11 intervention neighborhoods and six adjacent but similar 592 
neighborhoods due to the limited availability of eligible compounds remaining within 593 
intervention neighborhoods (Appendix 1-figure 9). Intervention selection criteria (5), (6), and (8) 594 
were not used to select control sites as they were deemed to be related to intervention 595 
construction and maintenance and unlikely to influence our outcomes. It was not possible to 596 




We enrolled eligible children at three time points: baseline (0 months), 12 months post-599 
intervention, and 24 months post-intervention. Children aged 1- 48 months old were eligible for 600 
baseline enrollment if we received written informed consent from a parent or guardian and if the 601 
head of the compound provided verbal assent for the compound to be included in the study. 602 
Children were eligible for enrollment at 12- and 24-month visits if they were aged 1-48 months 603 
or if they were eligible for enrollment at baseline but absent during that study visit. Children who 604 
moved into the compound fewer than six months before the 12-month or 24-month visit were not 605 
eligible for enrollment during that phase given their limited exposure to their new compound. 606 
Ethics 607 
The study protocol was approved by the Comité Nacional de Bioética para a Saúde (CNBS), 608 
Ministério da Saúde (333/CNBS/14), the Research Ethics Committee of the London School of 609 
Hygiene & Tropical Medicine (reference # 8345), and the Institutional Review Board of the 610 
Georgia Institute of Technology (protocol # H15160).  611 
Procedures 612 
Trained field enumerators completed consent procedures and surveys in the participant’s 613 
preferred language (Portuguese or Changana) and collected biological specimens from enrolled 614 
children (Appendix 1- Consent procedures, survey administration, and specimen collection and 615 
analysis). At baseline, we aimed to visit intervention compounds two weeks prior to the opening 616 
of the new latrines. We scheduled follow-up visits to be 12 months (±2 weeks) and 24 months 617 
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(±2 weeks) from the date compound members began using their new latrines, with visits to 618 
control compounds made concurrently (±2 weeks). 619 
We collected stool samples independently of reported symptomology. If we were unable to 620 
collect a stool sample after multiple attempts, a registered nurse collected a rectal swab after 621 
obtaining written consent for the procedure from a parent or guardian. Stool samples were kept 622 
cold and delivered to the Laboratory of Molecular Parasitology at the Instituto Nacional de 623 
Saúde (INS) within six hours of collection for analysis and storage at -80°C.  624 
Samples were shipped frozen with temperatures monitors to the Georgia Institute of Technology 625 
(Atlanta, USA) where we used the xTAG Gastrointestinal Pathogen Panel (Luminex Corp, 626 
Austin, USA), a qualitative multiplex molecular assay, to detect 15 enteric pathogens in stool 627 
samples: Campylobacter jejuni/coli/lari; Clostridium difficile, toxin A/B; enterotoxigenic 628 
Escherichia coli (ETEC) LT/ST; Shiga-like toxin producing E. coli (STEC) stx1/stx2; E. coli 629 
O157; Salmonella; Shigella boydii/sonnei/flexneri/dysenteriae; Vibrio cholerae; Yersinia 630 
enterocolitica; Giardia lamblia; Cryptosporidium parvum/hominis; Entamoeba histolytica; 631 
adenovirus 40/41; norovirus GI/GII; and rotavirus. The GPP has been rigorously tested and 632 
extensively used for stool-based enteric pathogen detection (Chisenga et al., 2018; Claas, 633 
Burnham, Mazzulli, Templeton, & Topin, 2013; Deng et al., 2015; Duong et al., 2016; Huang et 634 
al., 2016; Kellner et al., 2019; Khare et al., 2014; Navidad, Griswold, Gradus, & Bhattacharyya, 635 
2013; Patel, Navidad, & Bhattacharyya, 2014). We analyzed samples according to manufacturer 636 
instructions with the addition of elution steps for the pretreatment of rectal swabs and diaper 637 
material saturated with liquid stool (Appendix 1- Consent procedures, survey administration, and 638 
specimen collection and analysis). Technicians at INS assessed stool samples for the presence of 639 
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soil-transmitted helminths (STH) using the single-slide Kato-Katz microscope method 640 
(Vestergaard Frandsen, Lausanne, Switzerland).  641 
Representatives of the National Deworming Campaign (NDC) at the Mozambican Ministério da 642 
Saúde (MISAU) offered single-dose albendazole (400 mg, 200 mg for children aged six to 12 643 
months) to all eligible members of intervention and control compounds following sample 644 
collection activities of each phase. Eligibility was defined by the NDC and included compound 645 
members older than six months who were not pregnant.   646 
Outcomes 647 
For the 12-month analysis, we pre-specified the primary outcome as infection with one or more 648 
of the 12 bacterial or protozoan enteric pathogens detected by the GPP and secondary outcomes 649 
as re-infection with one or more STH as detected by Kato-Katz (following albendazole treatment 650 
at baseline), and seven-day period prevalence of caregiver-reported diarrhea. All three outcomes 651 
were considered secondary outcomes in the 24-month analysis. We defined diarrhea as the 652 
passage of three or more loose or liquid stools in a 24-hour period or any stool with blood 653 
(Arnold et al., 2013; Baqui et al., 1991). We excluded viral enteric pathogens from the primary 654 
outcome definition. The intervention may not have interrupted virus transmission due to their 655 
low infectious doses, high concentration shed in feces and extended period of shedding, 656 
environmental persistence, and capability for direct person-to-person transmission (Julian, 2016). 657 
Following reported specificity issues with the Salmonella target of the GPP, we removed it from 658 
our GPP-based outcome definitions (Duong et al., 2016; Kellner et al., 2019). In addition to the 659 
pre-specified outcomes, we evaluated the effect of the intervention on specific pathogen types 660 
(bacterial, protozoan, viral) and on individual pathogens. The results for other secondary 661 
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outcomes listed in the trial registration (growth and environmental enteric dysfunction) will be 662 
published separately.  663 
Statistical analysis 664 
Our sample size calculation has been described previously (Brown et al., 2015). We included all 665 
enrolled children at each visit and analysed data as repeated cross-sectional observations. We 666 
examined the effect of the intervention at the 12-month and 24-month phases separately. We 667 
conducted two sets of exploratory sub-group analyses. The first assessed the effect of the 668 
intervention on children with repeat observations at baseline and 12-months and at baseline and 669 
24-months visits. These longitudinal analyses also served as sensitivity analyses of the impact of 670 
participant migration on effect estimates. The second sub-group analysis compared children who 671 
were born into study sites after the intervention (or after baseline in controls) but before the 12-672 
month or 24-month visit with children of a similar age group at baseline. For example, children 673 
born after baseline but before the 24-month visit were compared with children aged two years 674 
old or younger at baseline. These analyses allowed us to explore whether exposure to the 675 
intervention from birth would reduce enteric pathogen infection during the first 1-2 years of life. 676 
We used a DID approach to assess the impact of the intervention on all outcomes at the 12- and 677 
24-month visits. We used generalized estimating equations (GEE) to fit Poisson regression 678 
models with robust standard errors. Our GEE models accounted for clustering at the compound 679 
level because it was the highest level of nested data and the level of the intervention allocation 680 
(Bottomley, Kirby, Lindsay, & Alexander, 2016). We estimated the effect of the intervention as 681 
the interaction of variables representing treatment status (intervention versus control) and phase 682 
(pre- or post-intervention). Therefore, effect estimates from our DID analysis are presented as 683 
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ratio measures (ratio of prevalence ratios) instead of absolute differences. Multivariable models 684 
were adjusted for covariates determined a priori as potentially predictive of our outcomes, 685 
including child age and sex, caregiver’s education, and household wealth. Given the important 686 
and potentially non-linear relationship between age and pathogen prevalence (Appendix 1-figure 687 
4), we also considered inclusion of a higher order age term (age squared) in our models 688 
(Appendix 1-table 10). Additional covariates (Appendix 1-table 9) were considered for inclusion 689 
in multivariable models if they were imbalanced between arms at baseline (>0.1 standardized 690 
difference in prevalence or mean) and resulted in a meaningful change in the DID effect estimate 691 
(±10% change in 12-month DID prevalence ratio). We assessed the potential impact of 692 
seasonality on our results in three ways: (1) inclusion of binary indicator of wet (November – 693 
April) and dry (May – October) season in multivariable models, (2) inclusion of a variable 694 
representing cumulative rainfall (mm) 30 days prior to sample or survey collection in 695 
multivariable models, and (3) inclusion of sine and cosine functions of sample and survey dates 696 
in multivariable models (Appendix 1-table 9 and Appendix 1-table 11). We used the same 697 
statistical approach for sub-group analyses. All analyses were performed on complete case data, 698 
and a missing data table is presented in Appendix 1 (Appendix 1-table 16). We performed all 699 
statistical analyses with Stata version 16 (StataCorp, College Station, USA).  700 
Registration 701 
The trial was pre-registered at ClinicalTrials.gov (NCT02362932). 702 
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Figure 1: Trial profile. †Eligible for enrollment at baseline and/or 12-month but traveling at time of visit. ‡Children 1107 
removed from 24-month analysis because their compound received an intervention after completion of the baseline 1108 
phase. Source files available in Figure 1 – source data 1 and Figure 1 – source code 1. 1109 
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Table 1: Baseline characteristics of enrolled children, households, and compounds 1110 
 
Control Intervention 
 N n (%) or mean (SD) N n (%) or mean (SD) 
Child level variables 
    
Age at survey, days† 520 700 (405) 441 694 (403) 
Sex, female  520 266 (51%) 444 227 (51%) 
Child is breastfed with or without complementary feeding 526 169 (32%) 448 143 (32%) 
Child is exclusively breastfed 526 49 (9.3%) 448 37 (8.3%) 
Child feces reported to be disposed of in a latrine 526 148 (28%) 448 141 (31%) 
Child wears diapers 526 342 (65%) 447 294 (66%) 
Caregiver completed primary school 528 287 (54%) 451 239 (53%) 
Child's mother is alive 513 503 (98%) 435 426 (98%) 
Respondent is child's mother 519 368 (71%) 443 284 (64%) 
Household level variables 
    
Household population 441 5.4 (2.4) 365 6.1 (3.0) 
Household wealth score, 0 (poorer) - 1 (wealthier)
*
 440 0.45 (0.10) 365 0.44 (0.10) 
Household crowding, >3 persons/room 440 54 (12%) 365 60 (17%) 
Household floor is covered‡ 440 426 (97%) 365 333 (91%) 
Household wall made of bricks, concrete, or similar‡ 440 304 (69%) 365 215 (59%) 
Household drinking water source inside compound 435 324 (74%) 360 294 (82%) 
Latrine used by household has a ceramic or masonry pedestal‡ 432 153 (35%) 359 142 (40%) 
Latrine used by household has a drop-hole cover‡ 434 232 (53%) 359 224 (62%) 
Compound level variables 
    
Number of compound members 287 14 (6.2) 208 19 (12) 
Number of households 287 3.8 (2.1) 208 4.4 (3.7) 
Number of water taps in compound 283 0.98 (0.95) 207 1.4 (1.6) 
Number of latrines in compound 287 1.0 (0.20) 207 1.1 (0.57) 
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Number of people sharing a latrine 285 14 (6.2) 197 17 (8.9) 
Number of households sharing a latrine 285 3.7 (1.8) 197 4.0 (2.8) 
Latrine walls made of brick, concrete or similar‡ 282 72 (26%) 204 67 (33%) 
Compound population density, persons/square meter⁑ 281 0.071 (0.04) 205 0.087 (0.05) 
Compound has electricity that normally functions 287 251 (87%) 208 189 (91%) 
Compound is prone to flooding 287 184 (64%) 208 120 (58%) 
Any animals observed in compound‡ 287 170 (59%) 208 132 (63%) 
Dog(s) observed‡ 287 14 (4.9%) 208 14 (6.7%) 
Chicken(s) or duck(s) observed‡ 287 40 (14%) 208 30 (14%) 
Cat(s) observed‡ 287 149 (52%) 208 116 (56%) 
Data are n (%) or mean (standard deviation) and collected by questionnaire unless otherwise noted. † Age range 32-1819 days, IQR 339-1021 days. Age 1111 
distributions available in Appendix 1-figure 3.  
*
Assessed using Simple Poverty Scorecard for Mozambique 1112 
(http://www.simplepovertyscorecard.com/MOZ_2008_ENG.pdf), 
‡
Data collected by direct observation. ⁑Calculated as # of people living in the compound 1113 
divided by the area of the compound in square meters. Source files available in Table 1 – source data 1 and Table 1 – source code 1. 1114 
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Table 2: Effect of the intervention on bacterial, protozoan, and STH infection and diarrhea at 12 and 24 months post-intervention. 1115 
 
Prevalence 
12 month Prevalence ratio (95% CI), 
p-value * 
24 month Prevalence ratio (95% CI), 
p-value ⁑ 
 Baseline 12-month 24-month unadjusted adjusted† unadjusted adjusted† 
Any bacterial or 
protozoan infection‡        
Control 313/392 (80%) 334/395 (85%) 403/459 (88%) .. .. .. .. 
Intervention 
278/361 (77%) 347/408 (85%) 392/462 (85%) 
1.04 (0.94 - 1.15), 
p=0.41 
1.04 (0.94 - 1.15), 
p=0.41 
1.00 (0.91 - 1.10), 
p=1.0 
0.99 (0.91 - 1.09), 
p=0.89 
Any STH infection‡ 
   
  
  
Control 170/360 (47%) 143/283 (51%) 142/253 (56%) .. .. .. .. 
Intervention 
138/329 (42%) 150/305 (49%) 136/292 (47%) 
1.12 (0.89 - 1.40), 
p=0.33 
1.11 (0.89 - 1.38), 
p=0.35 
0.94 (0.75 - 1.17), 
p=0.59 
0.95 (0.77 - 1.17), 
p=0.62 
Diarrhea‡ 
       
Control 67/526 (13%) 40/430 (9.3%) 53/390 (14%) .. .. .. .. 
Intervention 
59/448 (13%) 59/436 (14%) 53/410 (13%) 
1.41 (0.80 - 2.48), 
p=0.24 
1.69 (0.89 - 3.21), 
p=0.11  
0.92 (0.55 - 1.54), 
p=0.76 
0.84 (0.47 - 1.51), 
p=0.56 
Any Bacteria 
       
Control 271/392 (69%) 285/395 (72%) 345/459 (75%) .. .. .. .. 
Intervention 
227/361 (63%) 292/408 (72%) 324/462 (70%) 
1.09 (0.95 - 1.25), 
p=0.25 
1.09 (0.95 - 1.26), 
p=0.20 
1.03 (0.90 - 1.18), 
p=0.69 
1.00 (0.87 - 1.15), 
p=0.96 
Shigella 
   
  
  
Control 179/392 (46%) 204/395 (52%) 269/459 (59%) .. .. .. .. 
Intervention 
152/361 (42%) 218/408 (53%) 245/462 (53%) 
1.13 (0.91 - 1.39), 
p=0.28 
1.12 (0.92 - 1.38), 
p=0.27 
0.98 (0.80 - 1.20), 
p=0.86 





     
Control 116/392 (30%) 142/395 (36%) 127/459 (28%) .. .. .. .. 
Intervention 
110/361 (30%) 143/408 (35%) 126/462 (27%) 
0.93 (0.68 - 1.28), 
p=0.66 
0.96 (0.69 - 1.33), 
p=0.81 
0.95 (0.67 - 1.35), 
p=0.77 
0.83 (0.57 - 1.19), 
p=0.31 
Campylobacter 
   
  
  
Control 39/392 (9.9%) 32/395 (8.1%) 48/459 (10%) .. .. .. .. 
Intervention 
21/361 (5.8%) 35/408 (8.6%) 34/462 (7.4%) 
1.78 (0.89 - 3.56), 
p=0.10 
1.68 (0.82 - 3.45), 
p=0.16 
1.20 (0.60 - 2.39), 
p=0.60 
1.28 (0.62 - 2.62), 
0.50 
C. difficile 
       




13/361 (3.6%) 17/408 (4.2%) 11/462 (2.4%) 
1.95 (0.71 - 5.35), 
p=0.20 
2.09 (0.77 - 5.64), 
p=0.15 
1.32 (0.47 - 3.73), 
p=0.60 
1.41 (0.46 - 4.30), 
p=0.54 






Control 13/392 (3.3%) 19/395 (4.8%) 25/459 (5.5%) .. .. .. .. 
Intervention 
18/361 (5.0%) 14/408 (3.4%) 16/462 (3.5%) 
0.48 (0.18 - 1.27), 
p=0.14 
0.46 (0.18 - 1.21), 
p=0.12 
0.43 (0.15 - 1.29), 
p=0.13 





     
Control 3/392 (0.77%) 9/395 (2.3%) 17/459 (3.7%) .. .. .. .. 
Intervention 
10/361 (2.8%) 5/408 (1.2%) 15/462 (3.3%) 
0.14 (0.03 - 0.67), 
p=0.014 
0.15 (0.03 - 0.70), 
p=0.016 
0.23 (0.05 - 1.03), 
p=0.055 
0.24 (0.05 - 1.01), 
p=0.052 
Any Protozoa 
       
Control 205/392 (52%) 236/395 (60%) 303/459 (66%) .. .. .. .. 
Intervention 
195/361 (54%) 259/408 (63%) 296/462 (64%) 
1.04 (0.87 - 1.24), 
p=0.69 
1.03 (0.86 - 1.22), 
p=0.76 
0.93 (0.78 - 1.11), 
p=0.40 





     
Control 201/392 (51%) 230/395 (58%) 294/459 (64%) .. .. .. .. 
Intervention 
186/361 (52%) 251/408 (62%) 289/462 (63%) 
1.06 (0.88 - 1.27), 
p=0.55 
1.05 (0.88 - 1.25), 
p=0.58 
0.96 (0.80 - 1.14), 
p=0.61 





     
Control 8/392 (2%) 8/395 (2%) 14/459 (3.0%) .. .. .. .. 
Intervention 
16/361 (4.4%) 15/408 (3.7%) 15/462 (3.3%) 
0.89 (0.23 - 3.43), 
p=0.87 
0.89 (0.24 - 3.31), 
p=0.86 
0.46 (0.11 - 1.93), 
p=0.29 
0.53 (0.13 - 2.14), 
p=0.37 
Any virus 
       
Control 53/392 (14%) 52/395 (13%) 59/459 (13%) .. .. .. .. 
Intervention 
52/361 (14%) 45/408 (11%) 62/462 (13%) 
0.77 (0.45 - 1.32), 
p=0.35 
0.75 (0.44 - 1.27), 
p=0.29 
0.96 (0.55 - 1.68), 
p=0.88 





     
Control 38/392 (9.7%) 44/395 (11%) 47/459 (10%) .. .. .. .. 
Intervention 
39/361 (11%) 37/408 (9.1%) 55/462 (12%) 
0.71 (0.38 - 1.33), 
p=0.28 
0.68 (0.36 - 1.27), 
p=0.23 
1.00 (0.52 - 1.93), 
p=0.99 
1.10 (0.55 - 2.18), 
p=0.79 
Adenovirus 40/41 
       
Control 13/392 (3.3%) 9/395 (2.3%) 7/459 (1.5%) .. .. .. .. 
Intervention 
9/361 (2.5%) 9/408 (2.2%) 6/462 (1.3%) 
1.34 (0.34 - 5.23), 
p=0.68 
1.24 (0.32 - 4.83), 
p=0.76 
1.18 (0.23 - 5.98), 
p=0.84 
0.97 (0.18 - 5.19), 
p=0.97 




Control 206/392 (53%) 237/395 (60%) 302/459 (66%) .. .. .. .. 
Intervention 
185/361 (51%) 257/408 (63%) 282/462 (61%) 
1.08 (0.90 - 1.29), 
p=0.39 
1.08 (0.91 - 1.29), 
p=0.37 
0.95 (0.80 - 1.12), 
p=0.54 
0.93 (0.79 - 1.10), 
p=0.41 
Trichuris 
       
Control 139/360 (39%) 116/283 (41%) 124/253 (49%) .. .. .. .. 
Intervention 
117/329 (36%) 120/305 (39%) 117/292 (40%) 
1.05 (0.82 - 1.35), 
p=0.68  
1.01 (0.79 - 1.28), 
p=0.96 
0.89 (0.69 - 1.16), 
p=0.40 
0.86 (0.67 - 1.10), 
p=0.22 
Ascaris 
       
Control 95/360 (26%) 82/283 (29%) 78/253 (31%) .. .. .. .. 
Intervention 
68/329 (21%) 87/305 (29%) 56/292 (19%) 
1.26 (0.87 - 1.82), 
p=0.22 
1.33 (0.92 - 1.93), 
p=0.13 
0.80 (0.52 - 1.21), 
p=29 
0.83 (0.54 - 1.27), 
p=0.39 
Coinfection, ≥2 STH 
       
Control 64/360 (18%) 55/283 (19%) 60/253 (24%) .. .. .. .. 
Intervention 
47/329 (14%) 57/305 (19%) 37/292 (13%) 
1.16 (0.76 - 1.77), 
p=0.50 
1.17 (0.76 - 1.79), 
p=0.49 
0.67 (0.40 - 1.13), 
p=0.13 
0.63 (0.37 - 1.07), 
p=0.084 
Prevalence results are presented as (n/N (%)). All effect estimates are presented as prevalence ratios (ratio of ratios) and estimated using 1116 
generalized estimating equations to fit Poisson regression models with robust standard errors. *Analysis includes all children measured at baseline 1117 
and 12-month visits. ⁑Analysis includes all children measured at baseline and 24-month visits. ‡Outcome was pre-specified in trial registration. 1118 
All other outcomes are exploratory. †Pathogen outcomes adjusted for child age and sex, caregiver’s education, and household wealth index. 1119 
Reported diarrhea was also adjusted for baseline presence of a drop-hole cover and reported use of a tap on compound grounds as primary 1120 
drinking water source. Sample sizes for adjusted analyses are slightly smaller than numbers presented in prevalence estimates due to missing 1121 
covariate data. Y. enterocolitica, V. cholerae, E. histolytica, and rotavirus were detected in <2% of samples in each arm at each phase. Descriptive 1122 
data for these pathogens are available in the Appendix 1-table 2. Source files available in Table 2 – source data 1 and Table 2 – source code 1. 1123 
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Table 3: Effect of intervention on bacterial, protozoan, and STH infection and reported diarrhea in children born into study sites post-intervention (post-baseline) 1124 
but by 24-month visit compared with children of a similar age at baseline (<2 years old).  1125 
 
Prevalence (<2 years old) Prevalence ratio (95% CI), p-value 
 
Baseline 24-month, Born-in unadjusted adjusted† 
Any bacterial or protozoan 
infection‡     
Control 158/228 (69%) 79/106 (75%) .. .. 
Intervention 129/201 (64%) 71/107 (66%) 0.96 (0.77 - 1.21), p=0.74 0.99 (0.80 - 1.22), p=0.92 
Any STH infection‡ 
    
Control 67/205 (33%) 25/68 (37%) .. .. 
Intervention 52/183 (28%) 13/75 (17%) 0.52 (0.26 - 1.05), p=0.069 0.51 (0.27 - 0.95), p=0.035 
Diarrhea‡ 
    
Control 46/283 (16%) 18/105 (17%) .. .. 
Intervention 43/238 (18%) 22/100 (22%) 1.20 (0.57 -2.5), p=0.64 1.37 (0.47 - 4.03), p=0.57 
Any Bacteria 
    
Control 142/228 (62%) 70/106 (66%) .. .. 
Intervention 102/201 (51%) 51/107 (48%) 0.89 (0.66 - 1.20), p=0.44 0.90 (0.67 - 1.19), p=0.45 
Shigella 
    
Control 67/228 (29%) 36/106 (34%) .. .. 
Intervention 49/201 (24%) 15/107 (14%) 0.48 (0.28 - 0.83), p=0.009 0.49 (0.28 - 0.85), p=0.011 
ETEC 
    
Control 70/228 (31%) 30/106 (28%) .. .. 
Intervention 58/201 (29%) 24/107 (22%) 0.84 (0.46 - 1.52), p=0.56 0.85 (0.48 - 1.51), p=0.58 
Campylobacter 
    
Control 27/228 (12%) 14/106 (13%) .. .. 
Intervention 14/201 (7%) 13/107 (12%) 1.75 (0.63 - 4.87), p=0.29 1.75 (0.61 - 4.98), p=0.30 
C. difficile 
    
Control 20/228 (8.8%) 7/106 (6.6%) .. .. 
Intervention 13/201 (6.5%) 7/107 (6.5%) 1.33 (0.36 - 4.86), p=0.67 1.49 (0.41 - 5.44), p=0.55 
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E. coli O157 
    
Control 7/228 (3.1%) 3/106 (2.8%) .. .. 
Intervention 9/201 (4.5%) 2/107 (1.9%) 0.45 (0.06 - 3.66), p=0.46 0.53 (0.07 - 4.24), p=0.55 
STEC 
    
Control 1/228 (0.44%) 2/106 (1.9%) .. .. 
Intervention 9/201 (4.5%) 1/107 (0.93%) 0.05 (0.00 - 1.13), p=0.059 0.05 (0.00 - 1.26), p=0.070 
Any Protozoa 
    
Control 82/228 (36%) 47/106 (44%) .. .. 
Intervention 74/201 (37%) 43/107 (40%) 0.84 (0.55 - 1.28), p=0.42 0.90 (0.62 - 1.30), p=0.58 
Giardia 
    
Control 79/228 (35%) 44/106 (42%) .. .. 
Intervention 68/201 (34%) 41/107 (38%) 0.90 (0.58 - 1.39), p=0.63 0.93 (0.64 - 1.36), p=0.70 
Cryptosporidium 
    
Control 7/228 (3.1%) 5/106 (4.7%) .. .. 
Intervention 12/201 (6%) 5/107 (4.7%) 0.45 (0.08 - 2.57), p=0.37 0.64 (0.12 - 3.51), p=0.61 
Any virus 
    
Control 34/228 (15%) 18/106 (17%) .. .. 
Intervention 36/201 (18%) 18/107 (17%) 0.83 (0.37 - 1.83), p=0.64 0.83 (0.37 - 1.87), p=0.66 
Norovirus GI/GII 
    
Control 26/228 (11%) 12/106 (11%) .. .. 
Intervention 26/201 (13%) 17/107 (16%) 1.24 (0.48 - 3.17), p=0.66 1.29 (0.49 - 3.41), p=0.61 
Adenovirus 40/41 
    
Control 7/228 (3.1%) 4/106 (3.8%) .. .. 
Intervention 7/201 (3.5%) 0/107 (0.0%) ..⁂ ..⁂ 
Coinfection, ≥2 GPP pathogens 
    
Control 92/228 (40%) 52/106 (49%) .. .. 
Intervention 74/201 (37%) 39/107 (36%) 0.82 (0.56 - 1.21), p=0.33 0.86 (0.59 - 1.24), p=0.41 
Trichuris 
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Control 48/205 (23%) 18/68 (26%) .. .. 
Intervention 41/183 (22%) 5/75 (6.7%) 0.25 (0.09 - 0.68), p=0.006 0.24 (0.10 - 0.60), p=0.002 
Ascaris 
    
Control 45/205 (22%) 16/68 (24%) .. .. 
Intervention 29/183 (16%) 9/75 (12%) 0.70 (0.30 - 1.64), p=0.42 0.68 (0.30 - 1.54), p=0.36 
Coinfection, ≥2 STH 
    
Control 26/205 (13%) 9/68 (13%) .. .. 
Intervention 18/183 (9.8%) 1/75 (1.3%) 0.13 (0.02 - 1.08), p=0.059 0.12 (0.01 - 1.02), p=0.052 
Analysis includes children <2 years old at baseline and children born into the study after baseline and <2 years old at the time of the 24-month 1126 
visit. Prevalence results are presented as (n/N (%)). All effect estimates are presented as prevalence ratios (ratio of ratios) and estimated using 1127 
generalized estimating equations to fit Poisson regression models with robust standard errors ‡Outcome was pre-specified in trial registration. All 1128 
other outcomes are exploratory. †Pathogen outcomes adjusted for child age and sex, caregiver’s education, and household wealth index. Reported 1129 
diarrhea was also adjusted for baseline presence of a drop-hole cover and reported use of a tap on compound grounds as primary drinking water 1130 
source. Sample sizes for adjusted analyses are slightly smaller than numbers presented in prevalence estimates due to missing covariate data. 1131 
⁂Models would not converge due to sparse data. Y. enterocolitica, V. cholerae, E. histolytica, and rotavirus were detected in <2% of samples in 1132 
each arm at each phase and excluded. Descriptive data for these pathogens are available in the  Appendix 1-table 2. Source files available in 1133 
Table 3 – source data 1 and Table 3 – source code 1.1134 
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Consent procedures, survey administration, and specimen collection and analysis 6 
Enumerators visited households with enrolled children at least twice at each point of follow-up. On the 7 
first visit of each phase, enumerators completed consent procedures, administered child-, household-, and 8 
compound-level surveys, and delivered stool sample collection supplies. The child’s mother was the 9 
target respondent for child and household surveys, though the father or another guardian was also eligible. 10 
For compound-level surveys, the head of the compound or his or her spouse was the preferred respondent. 11 
We sought written, informed consent from the parent or guardian of each eligible child prior to initial 12 
enrollment. We sought verbal assent from parents or guardians at each follow-up visit. Consent 13 
procedures, surveys, and all study-related verbal communication was performed in Portuguese or 14 
Changana as requested by the participant. Written materials were provided in Portuguese. Enumerators 15 
provided each caregiver with stool collection supplies, including disposable diapers, a plastic potty if the 16 
child was no longer wearing diapers, and a pre-labeled sterile sample bag. Enumerators returned the next 17 
day to collect the specimens. If a specimen was unavailable during the scheduled pickup, caregivers 18 
called the field team, using phone credit provided by the study, as soon as one was available or if fresh 19 
collection supplies were needed. If field enumerators were unable to collect a stool sample after multiple 20 
attempts, a registered nurse used an anatomically designed rectal swab (Copan Diagnostics Inc, Murrieta, 21 
CA, USA) to collect fecal material. Parents or guardians were required to complete a separate written 22 
consent procedure prior to collection of rectal swabs. Stool specimens and rectal swabs were stored in 23 
coolers with cold packs and delivered to the Medical Parasitology Laboratory at the Mozambican 24 
Ministry of Health (MISAU/INS) within six hours of collection. Technicians at INS prepared Kato-Katz 25 
slides for soil-transmitted helminth (STH) detection the day of receipt and read results within 30 minutes 26 
of preparation for hookworm and within 24 hours for other STH. In addition to STH analysis, laboratory 27 
technicians at INS also aliquoted stools into several sterile tubes and stored them, and any rectal swabs, at 28 
-80°C. If a child produced a liquid stool, lab technicians stored a piece of the saturated diaper material 29 
(“diaper samples”) at -80°C. Stool samples were shipped frozen on dry ice with temperature probes to the 30 
Georgia Institute of Technology in Atlanta, Georgia, USA where they were stored at -80°C until analysis. 31 
We followed manufacturer instructions for the pretreatment, extraction, and analysis of stool samples by 32 
the Luminex Gastrointestinal Pathogen Panel (GPP), with additional elution steps added to the 33 
pretreatment protocol for rectal swabs and diaper samples. We eluted diaper samples in 2.5 mL of lysis 34 
buffer (ASL buffer, Qiagen, Hilden, Germany). We used a sterile 10-mL syringe to facilitate elution via 35 
agitation by taking in and expelling the buffer 5 times. We used 1 mL of the final eluate in the 36 
pretreatment. We agitated rectal swabs in 1 mL of lysis buffer for 1 minute and used the eluate in the 37 
pretreatment. Following pretreatment, we extracted DNA and RNA using the QIAcube HT platform and 38 
the QIAamp 96 Virus QIAcube HT Kit (Qiagen, Hilden, Germany). We added MS2, a non-pathogenic 39 
RNA virus, to each sample prior to nucleic acid extraction as an extraction and RT-PCR inhibition 40 
control. We included at least one sample process control (containing only lysis buffer and MS2) and 41 
negative extraction control (containing only lysis buffer) with each set of extractions. During the PCR 42 
step, we included at least one no-template control, containing molecular grade water and all PCR 43 
reagents, with each run. To assess elution and extraction of nucleic acid from swab and diaper samples, 44 
we measured the concentration of double-stranded DNA (dsDNA) present in a subset of extracts using the 45 
Qubit® High Sensitivity dsDNA kit (Invitrogen™, Carlsbad, CA, USA) and Qubit® 4 Fluorimeter 46 
(Invitrogen™, Carlsbad, CA, USA). The mean concentration of dsDNA recovered from rectal swabs was 47 
26.3 ng/L (SD 15.5, n=195, 25 swabs with measures above assay detection limit) and from diaper 48 
samples was 28.7 ng/L (SD 16.9, n=61, 16 diapers with measures above assay detection limit). The 49 
concentration of dsDNA recovered from whole stool exceeded the assay detection limits in most cases. 50 
The mean concentration of dsDNA in the subset of stools with measurable results was 40.8 ng/L 51 
(SD=16.5, n=33, 57 samples had concentrations above the assay detection limit). Following extraction, 52 
4 
 
we stored all extracts at 4°C and analyzed them by GPP within 24 hours. For long-term storage, we 53 
archived samples at -80°C. We extracted and analyzed approximately 10% of samples in duplicate 54 
(biological replicates). If duplicate analyses yielded different results, we combined the results from all 55 
analyses such that the final result captured all positive detections for a given sample. If we could not 56 
detect a MS2 signal in a given sample, we either re-extracted or diluted the extract 1:10 in molecular 57 




Appendix 1-figure 1: Proportion of each type of sample collected during the baseline, 12-month, and 24-month phases. Results 60 
stratified by study arm. Rectal swabs were not introduced until the 12-month phase of the study. 61 
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Appendix 1-table 1: Number and proportion of sample types collected in each arm at each phase. 62 
 
Baseline 12-month 24-month 
 
Control Intervention Control Intervention Control Intervention 
Whole stool 377 (96%) 351 (97%) 361 (91%) 380 (93%) 307 (67%) 333 (72%) 
Diarrheal diaper 15 (3.8%) 10 (2.8%) 4 (1.0%) 4 (0.98%) 32 (7.0%) 20 (4.3%) 
Rectal swab* 0 (0%) 0 (0%) 30 (7.6%) 24 (5.9%) 120 (26%) 109 (24%) 
* Mean concentration of double-stranded DNA recovered from whole stool was 40.8 ng/L (SD=16.5, n=33 with 57 samples 63 
excluded as their concentrations exceeded the upper detection limit of the assay), diaper samples was 28.7  ng/L (SD=16.9, n=61 64 
with 16 samples excluded as concentrations exceeded upper detection limit of assay), and from rectal swabs was 26.3 ng/L 65 
(SD=15.5, n=195 with 25 samples excluded as concentrations exceeded upper detection limit of assay). Only a subset of each sample 66 





Appendix 1-figure 2: Enrollment and stool sample collection profile. Graphs depict four week 70 
rolling average of the number of intervention and control children enrolled/visited (solid lines) 71 
and the number of stool samples collected (including whole stool, diaper samples, and rectal 72 
swabs) during the baseline, 12-month, and 24-month phases. The overall success of stool sample 73 
collection was 78% at baseline, 86% at 12-month, and 90% at 24-month. The increase in success 74 




Appendix 1-figure 3: Distribution of age (years) of enrolled children at each phase. Results are 77 
presented as kernel density plots and stratified by study arm (intervention=blue, control=green) 78 
and phase: (a) Baseline phase, (b) 12-month follow-up, (c) 24-month follow-up, and (d) All 79 
phases combined. 80 
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Appendix 1-table 2: Age stratified baseline prevalence of health outcomes.  81 
 Baseline Prevalence 
 1 - 11 months 12-23 months 24 - 48 months 
Any bacterial or protozoan infection    
All children 108/208 (52%) 179/221 (81%) 277/297 (93%) 
Control 57/109 (52%) 101/119 (85%) 143/152 (94%) 
Intervention 51/99 (52%) 78/102 (76%) 134/145 (92%) 
Any STH infection    
All children 30/185 (16%) 89/203 (44%) 171/277 (62%) 
Control 17/93 (18%) 50/112 (45%) 94/144 (65%) 
Intervention 13/92 (14%) 39/91 (43%) 77/133 (58%) 
Diarrhea    
All children 37/258 (14%) 52/264 (20%) 36/427 (8.4%) 
Control 19/138 (14%) 27/146 (18%) 20/234 (8.6%) 
Intervention 18/120 (15%) 25/118 (21%) 16/193 (8.3%) 
Any bacterial infection    
All children 94/208 (45%) 150/221 (68%) 229/297 (77%) 
Intervention 53/109 (49%) 89/119 (75%) 117/152 (77%) 
All children 41/99 (41%) 61/102 (60%) 112/145 (77%) 
Shigella    
All children 19/208 (9.1%) 97/221 (44%) 192/297 (65%) 
Control 10/109 (9.2%) 57/119 (48%) 101/152 (66%) 
Intervention 9/99 (9.1%) 40/102 (39%) 91/145 (63%) 
ETEC    
All children 47/208 (23%) 81/221 (37%) 90/297 (30%) 
Control 25/109 (23%) 45/119 (38%) 43/152 (28%) 
Intervention 22/99 (22%) 36/102 (35%) 47/145 (32%) 
Campylobacter    
All children 22/208 (11%) 19/221 (8.6%) 16/297 (5.4%) 
Control 14/109 (13%) 13/119 (11%) 10/152 (6.6%) 
Intervention 8/99 (8.1%) 6/102 (5.9%) 6/145 (4.1%) 
C. difficile    
All children 23/208 (11%) 10/221 (4.5%) 2/297 (0.67%) 
Control 13/109 (12%) 7/119 (5.9%) 2/152 (1.3%) 
Intervention 10/99 (10%) 3/102 (2.9%) 0/145 (0.0%) 
E. coli o157    
All children 6/208 (2.9%) 10/221 (4.5%) 15/297 (5%) 
Control 4/109 (3.7%) 3/119 (2.5%) 6/152 (4%) 
Intervention 2/99 (2%) 7/102 (6.9%) 9/145 (6.2%) 
STEC    
All children 3/208 (1.4%) 7/221 (3.2%) 3/297 (1%) 
Control 0/109 (0.0%) 1/119 (0.84%) 2/152 (1.3%) 
Intervention 3/99 (3%) 6/102 (5.9%) 1/145 (0.69%) 
Y. enterocolitica    
All children 0/208 (0.0%) 1/221 (0.45%) 0/297 (0.0%) 
Control 0/109 (0.0%) 0/119 (0.0%) 0/152 (0.0%) 
Intervention 0/99 (0.0%) 1/102 (0.98%) 0/145 (0.0%) 
V. cholerae    
10 
 
All children 0/208 (0.0%) 0/221 (0.0%) 0/297 (0.0%) 
Control 0/109 (0.0%) 0/119 (0.0%) 0/152 (0.0%) 
Intervention 0/99 (0.0%) 0/102 (0.0%) 0/145 (0.0%) 
Any Protozoa    
All children 36/208 (17%) 120/221 (54%) 223/297 (75%) 
Control 14/109 (13%) 68/119 (57%) 114/152 (75%) 
Intervention 22/99 (22%) 52/102 (51%) 109/145 (75%) 
Giardia    
All children 28/208 (13%) 119/221 (54%) 219/297 (74%) 
Control 12/109 (11%) 67/119 (56%) 113/152 (74%) 
Intervention 16/99 (16%) 52/102 (51%) 106/145 (73%) 
Cryptosporidium    
All children 10/208 (4.8%) 9/221 (4.1%) 5/297 (1.7%) 
Control 2/109 (1.8%) 5/119 (4.2%) 1/152 (0.66%) 
Intervention 8/99 (8.1%) 4/102 (3.9%) 4/145 (2.8%) 
E. histolytica    
All children 1/208 (0.48%) 0/221 (0.0%) 3/297 (1%) 
Control 0/109 (0.0%) 0/119 (0.0%) 0/152 (0.0%) 
Intervention 1/99 (1%) 0/102 (0.0%) 3/145 (2.1%) 
Any virus    
All children 36/208 (17%) 34/221 (15%) 33/297 (11%) 
Control 15/109 (14%) 19/119 (16%) 19/152 (13%) 
Intervention 21/99 (21%) 15/102 (15%) 14/145 (9.7%) 
Norovirus GI/GII    
All children 27/208 (13%) 25/221 (11%) 23/297 (7.7%) 
Control 12/109 (11%) 14/119 (12%) 12/152 (7.9%) 
Intervention 15/99 (15%) 11/102 (11%) 11/145 (7.6%) 
Adenovirus 40/41    
All children 7/208 (3.4%) 7/221 (3.2%) 8/297 (2.7%) 
Control 4/109 (3.7%) 3/119 (2.5%) 6/152 (4%) 
Intervention 3/99 (3%) 4/102 (3.9%) 2/145 (1.4%) 
Rotavirus A    
All children 3/208 (1.4%) 5/221 (2.3%) 2/297 (0.67%) 
Control 0/109 (0.0%) 2/119 (1.7%) 1/152 (0.66%) 
Intervention 3/99 (3%) 3/102 (2.9%) 1/145 (0.69%) 
Coinfection, ≥2 GPP pathogens    
All children 48/208 (23%) 118/221 (53%) 203/297 (68%) 
Control 23/109 (21%) 69/119 (58%) 104/152 (68%) 
Intervention 25/99 (25%) 49/102 (48%) 99/145 (68%) 
Trichuris    
All children 20/185 (11%) 69/203 (34%) 150/277 (54%) 
Control 10/93 (11%) 38/112 (34%) 82/144 (57%) 
Intervention 10/92 (11%) 31/91 (34%) 68/133 (51%) 
Ascaris    
All children 21/185 (11%) 53/203 (26%) 81/277 (29%) 
Control 12/93 (13%) 33/112 (29%) 47/144 (33%) 
Intervention 9/92 (9.8%) 20/91 (22%) 34/133 (26%) 
Coinfection, ≥2 STH    
11 
 
All children 11/185 (6%) 33/203 (16%) 60/277 (22%) 
Control 5/93 (5.4%) 21/112 (19%) 35/144 (24%) 
Intervention 6/92 (6.5%) 12/91 (13%) 25/133 (19%) 
Number of GPP infections    
All children 0.94 (1.1) 1.8 (1.2) 1.9 (0.95) 
Control 0.88 (1.1) 1.8 (1.1) 2 (0.93) 
Intervention 1 (1.1) 1.7 (1.3) 1.9 (0.98) 
Number of STH infections    
All children 0.23 (0.55) 0.61 (0.75) 0.86 (0.76) 
Control 0.24 (0.54) 0.64 (0.78) 0.9 (0.76) 
Intervention 0.23 (0.56) 0.57 (0.72) 0.8 (0.76) 
Data presented n/N (%) or mean (standard deviation). All bacterial, protozoan, and viral pathogens were 82 
measured using the Luminex Gastrointestinal Pathogen panel. STH were measured using the Kato-Katz 83 




Appendix 1-figure 4: Prevalence of pathogens by age at baseline, 12-month, and 24-month 86 
phases. Results are smoothed averages stratified by study arm with 95% confidence intervals 87 
represented by shaded areas.    88 
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Appendix 1-table 3: Baseline enrollment characteristics of children with and without repeated measures at the 12-month phase. 89 
Results are presented for all children combined and stratified by study arm.  90 
 




































































































































































































































































































































































































Number of GPP infections 1.6 (1.1) 1.7 (1.1) 0.07 1.6 (1.1) 1.6 (1.1) 0.02 1.6 (1.1) 1.7 (1.2) 0.14 














Child-, household-, compound-level characteristics 
















































Child age at survey, days 697 (409) 697 (396) 0.00 698 (409) 703 (400) 0.01 696 (409) 689 (391) 0.02 
Child age at sampling, days 668 (399) 656 (382) 0.03 661 (397) 655 (395) 0.02 674 (402) 657 (364) 0.04 





















































































































































































































































Leaking or standing wastewater 



















































































































Number of household members 6.4 (3.3) 5.6 (2.6) 0.27 6 (3) 5.2 (2.1) 0.33 6.8 (3.5) 6.3 (3.1) 0.18 
Household wealth score, 0-1 0.43 (0.1) 
0.44 
(0.099) 
0.10 0.44 (0.1) 
0.45 
(0.097) 
0.15 0.43 (0.1) 0.43 (0.1) 0.01 
Number of households in compound 5.2 (4.6) 4.7 (4.4) 0.11 4.4 (2.9) 3.8 (1.7) 0.21 6.1 (5.6) 6 (6.4) 0.02 
Compound population 21 (15) 19 (14) 0.18 17 (8.1) 15 (6.1) 0.22 26 (18) 24 (20) 0.11 
Number of water taps in compound 1.5 (2.2) 1.2 (1) 0.22 1 (1.1) 
0.97 
(0.83) 
0.04 2.1 (2.8) 1.4 (1.2) 0.30 
Number of latrines/drop-holes in 
compound 
1.1 (0.63) 1.1 (0.65) 0.00 1 (0.24) 1 (0.2) 0.04 1.2 (0.86) 1.3 (0.97) 0.03 
















Results are presented as prevalence (n/N (%)) or mean (standard deviation) at baseline. * Prevalence (or mean (SD)) for children with repeated 91 
observations at baseline and 12-month visits. † Prevalence (or mean (SD)) for children with observations at baseline visit and not the 12-month 92 
visit. ‡ Standardized mean difference between observations of children with and without repeated measures at baseline and 12-month visits. ⁑ 93 
Could not be calculated.    94 
  95 
17 
 
Appendix 1-table 4: Baseline enrollment characteristics of children with and without repeated measures at the 24-month phase. 96 
Results are presented for all children combined and stratified by study arm.  97 
 




































































































































































































































































































































































































Number of GPP infections 1.6 (1.1) 1.6 (1.2) 0.04 1.6 (1.1) 1.7 (1.1) 0.10 1.6 (1.1) 1.6 (1.2) 0.01 
















Child-, household-, compound-level characteristics 
















































Child age at survey, days 698 (403) 696 (405) 0.01 689 (400) 709 (410) 0.05 707 (406) 675 (398) 0.08 
Child age at sampling, days 675 (406) 651 (379) 0.06 666 (403) 652 (390) 0.04 682 (409) 650 (364) 0.08 





















































































































































































































































Leaking or standing wastewater 



















































































































Number of household members 6.7 (3.4) 5.5 (2.6) 0.39 6.3 (3) 5.2 (2.2) 0.42 7.1 (3.6) 6.1 (3) 0.31 











0.43 (0.1) 0.11 
Number of households in compound 5.3 (4.7) 4.7 (4.3) 0.13 4.4 (3.1) 3.9 (1.8) 0.21 6.1 (5.7) 5.9 (6.2) 0.03 
Compound population 22 (15) 18 (14) 0.26 17 (8.1) 15 (6.5) 0.27 27 (18) 23 (19) 0.18 
Number of water taps in compound 1.6 (2.2) 1.2 (1.3) 0.24 1 (1) 
0.99 
(0.92) 
0.02 2.2 (2.8) 1.4 (1.8) 0.31 
Number of latrines in compound 1.1 (0.62) 1.1 (0.65) 0.01 1 (0.25) 1 (0.19) 0.04 1.2 (0.82) 1.3 (0.99) 0.08 
















Results are presented as prevalence (n/N (%)) or mean (standard deviation) at baseline. * Prevalence (or mean (SD)) for children with repeated 98 
observations at baseline and 24-month visits. † Prevalence (or mean (SD)) for children with observations at the baseline visit and not the 24-month 99 
visit. ‡ Standardized mean difference between observations of children with and without repeated measures at baseline and 24-month visits. ⁑ 100 
Could not be calculated.    101 
 102 
  103 
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Appendix 1-table 5: Balance of characteristics measured at 12-month visits between children with repeat observations at baseline and 104 
12-month and children with observations at the 12-month phase only.  105 
 










































































































































Household walls made 



































































































Cat observed 469/611 249/324 0.00 218/309 118/164 0.03 251/302 131/160 0.03 0.24 
22 
 
(77%) (77%) (71%) (72%) (83%) (82%) 


















































Number of household 
members 
6.5 (3.2) 6.3 (3.3) 0.06 6.2 (3) 6.4 (3.5) 0.05 6.8 (3.3) 6.2 (3.2) 0.17 0.05 














0.4 (0.1) 0.10 0.11 
Number of households in 
compound 
5.2 (4.7) 5.4 (5.5) 0.04 4.2 (2.9) 4 (2.3) 0.09 6.3 (5.9) 6.9 (7.3) 0.09 0.53 


















Results are presented as prevalence (n/N (%)) or mean (standard deviation) at 12-month visit. * Prevalence (or mean (SD)) for children with 106 
repeated observations at baseline and 12-month visits. † Prevalence (or mean (SD)) for children with observations at the 12-month visit only. ‡ 107 
Standardized mean difference between observations of children with and without repeated measures at baseline and 12-month visits. ⁑ 108 
Standardized mean difference between observations from control and intervention children measured at 12-month visit only.  109 
 110 
  111 
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Appendix 1-table 6: Balance of characteristics measured at 24-month visits between children with repeat observations at baseline and 112 
24-month and children with observations at the 24-month phase only.  113 
 










































































































































Household walls made 



































































































Cat observed 360/507 340/494 0.05 154/245 174/254 0.12 206/262 166/240 0.22 0.01 
24 
 
(71%) (69%) (63%) (69%) (79%) (69%) 


















































Number of household 
members 
6.6 (3.1) 6.3 (3.4) 0.10 6.5 (3) 6.6 (3.8) 0.04 6.7 (3.1) 6 (2.8) 0.26 0.20 

















Number of households in 
compound 
5.3 (4.9) 5.5 (5.5) 0.04 4.3 (2.8) 4.4 (3.2) 0.03 6.2 (6.1) 6.6 (6.9) 0.06 0.41 


















Results are presented as prevalence (n/N (%)) or mean (standard deviation) at 24-month visit. * Prevalence (or mean (SD)) for children with 114 
repeated observations at baseline and 24-month visits. † Prevalence (or mean (SD)) for children with observations at the 24-month visit only. ‡ 115 
Standardized mean difference between observations of children with and without repeated measures at baseline and 24-month visits. ⁑ 116 
Standardized mean difference between observations from control and intervention children measured at 24-month visit only.  117 
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Appendix 1-table 7: Sensitivity analysis assessing the impact of reported deworming on STH effect estimates 12 and 24 months after 118 
the intervention. 119 
 




















n=1239 n=1239 n=1031 n=1161 n=1161 N=1159 
Any STH infection 1.11 (0.89 - 1.38) 1.09 (0.87 - 1.35) 1.06 (0.84 - 1.33) 0.95 (0.77 - 1.17) 0.93 (0.77 - 1.16) 0.93 (0.75 – 1.14) 
Trichuris 1.01 (0.79 - 1.28) 0.98 (0.77 - 1.24) 0.96 (0.74 - 1.23) 0.86 (0.67 - 1.10) 0.85 (0.66 - 1.08) 0.86 (0.67 – 1.09) 
Ascaris 1.33 (0.92 - 1.93) 1.30 (0.90 - 1.88) 1.30 (0.87 - 1.94) 0.83 (0.54 - 1.27) 0.84 (0.55 - 1.29) 0.78 (0.51 – 1.18) 
Coinfection, ≥2 STH 1.17 (0.76 - 1.79) 1.12 (0.73 - 1.71) 1.16 (0.73 - 1.85) 0.63 (0.37 - 1.07) 0.63 (0.37 - 1.08) 0.60 (0.35 – 1.03) 
All effect estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized estimating 120 
equations to fit Poisson regression models with robust standard errors. All models adjusted for child age, sex, caregiver education level, and 121 
household wealth. *Analysis includes all children regardless of caregiver-reported deworming status.  †Analysis is adjusted for reported 122 
deworming status. Effect estimates at 12-month are adjusted for baseline deworming confirmation, effect estimates at 24-month are adjusted for 123 
baseline and/or 12-month deworming confirmation. ‡Analysis is restricted to children whose caregivers confirmed baseline deworming. ⁑ 124 
Adjusted for time between 12-month deworming and 24-month sample collection, time broken into 3 intervals: 0-3 months, 4-6 months, and >6 125 
months. The NDC performed 12-month deworming activities at the end of the 12-month phase instead of concurrent to 12-month sample 126 
collection resulting in some variation in the amount of time between 12-month deworming and 24-month sample collection among participants. 127 
All samples collected during 12-month phase were collected >6 months after deworming and no adjustment for time since deworming was made.   128 
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Appendix 1-table 8: Sensitivity analysis assessing impact of independent upgrading of control sanitation facilities on effect estimates. 129 
 
12-month adjusted prevalence ratio 24-month adjusted prevalence ratio 
 
Main analysis, all 
children* 
Excluding controls with 
upgraded sanitation† 
Main analysis, all 
children* 
Excluding controls with 
upgraded sanitation† 
Any bacterial or protozoan 
infection 
1.04 (0.94 – 1.15), 
n=1510 
1.05 (0.95 – 1.16), 
n=1491 
0.99 (0.91 – 1.09), 
n=1536 
1.00 (0.91 – 1.10), 
n=1502 
Any STH infection 
1.11 (0.89 – 1.38), 
n=1239 
1.11 (0.89 – 1.38), 
n=1225 
0.95 (0.77 – 1.17), 
n=1161 
0.94 (0.76 – 1.16), 
n=1148 
Diarrhea 
1.69 (0.89 – 3.21), 
n=1594 
1.76 (0.91 – 3.39), 
n=1575 
0.84 (0.47 – 1.51), 
n=1502 
0.81 (0.45 – 1.48), 
n=1471 
All effect estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized estimating 130 
equations to fit Poisson regression models with robust standard errors. All infection outcomes are adjusted for child age and sex, caregiver’s 131 
education, and household wealth index, and the diarrhea outcome is also adjusted for baseline presence of a drop-hole cover and reported use of a 132 
tap on compound grounds as primary drinking water source. * Results represent effect estimates for the main analyses which included control 133 
children irrespective of whether their latrines had been independently upgraded (results also presented in Table 2 in main text).  † Results from 134 
sensitivity analyses which exclude control children living in compounds that independently upgraded their latrines to be similar to the intervention.  135 
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Appendix 1-table 9: Confounding assessment for primary outcome and both secondary outcomes (any STH, diarrhea) at 12-month. 136 
 
n/N (%) or mean 






































(0.94 - 1.15) 
Comparator 
aPR: 1.04 
(0.94 - 1.15) 
Comparator 
PR: 1.12 
(0.89 - 1.40) 
Comparator 
aPR: 1.11 
(0.90 - 1.38) 
Comparator 
PR: 1.41 
(0.80 - 2.48) 
Comparator 
aPR: 1.32 






1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.14 (0.91 - 
1.42) 
1.11 (0.89 - 
1.38) 
1.39 (0.79 - 
2.46) 
1.32 (0.75 - 
2.33) 





1.05 (0.95 - 
1.15) 
1.05 (0.95 - 
1.15) 
1.11 (0.90 - 
1.38) 
1.11 (0.90 - 
1.38) 
1.39 (0.79 - 
2.45) 









1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.12 (0.90 - 
1.41) 
1.11 (0.89 - 
1.38) 
1.40 (0.80 - 
2.48) 









1.05 (0.95 - 
1.16) 
1.04 (0.94 - 
1.15) 
1.13 (0.90 - 
1.42) 
1.11 (0.89 - 
1.38) 
1.37 (0.78 - 
2.42) 









1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.12 (0.89 - 
1.40) 
1.12 (0.90 - 
1.39) 
1.39 (0.79 - 
2.47) 
1.32 (0.74 - 
2.34) 
Household walls 






0.21 1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.12 (0.89 - 
1.40) 
1.11 (0.89 - 
1.38) 
1.41 (0.80 - 
2.48) 
1.32 (0.75 - 
2.33) 
Drinking water 






1.03 (0.93 - 
1.15) 
1.03 (0.93 - 
1.14) 
1.08 (0.85 - 
1.36) 
1.05 (0.83 - 
1.33) 
1.65 (0.89 - 
3.06) 
1.59 (0.85 - 
2.95) 







1.03 (0.93 - 
1.13) 
1.03 (0.93 - 
1.13) 
1.14 (0.91 - 
1.43) 
1.12 (0.90 - 
1.40) 
1.43 (0.81 - 
2.54) 
1.35 (0.76 - 
2.40) 
Compound floods 






1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.12 (0.89 - 
1.40) 
1.11 (0.89 - 
1.38) 
1.41 (0.80 - 
2.49) 









1.04 (0.94 - 
1.15) 
1.03 (0.93 - 
1.15) 
1.11 (0.88 - 
1.40) 
1.08 (0.85 - 
1.36) 
1.74 (0.92 - 
3.30) 









0.09 1.04 (0.94 - 
1.15) 
1.04 (0.93 - 
1.15) 
1.10 (0.87 - 
1.39) 
1.07 (0.85 - 
1.35) 
1.71 (0.90 - 
3.24) 
1.65 (0.87 - 
3.14) 
Latrine walls made 






1.03 (0.93 - 
1.14) 
1.03 (0.93 - 
1.13) 
1.14 (0.91 - 
1.43) 
1.12 (0.90 - 
1.40) 
1.42 (0.80 - 
2.51) 











0.38 1.03 (0.93 - 
1.14) 
1.03 (0.93 - 
1.13) 
1.14 (0.91 - 
1.42) 
1.12 (0.90 - 
1.39) 
1.42 (0.80 - 
2.51) 
1.34 (0.75 - 
2.38) 







0.33 1.03 (0.93 - 
1.14) 
1.03 (0.93 - 
1.13) 
1.14 (0.91 - 
1.43) 
1.12 (0.90 - 
1.40) 
1.42 (0.80 - 
2.51) 









0.16 1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.11 (0.89 - 
1.39) 
1.11 (0.89 - 
1.38) 
1.41 (0.80 - 
2.48) 
1.32 (0.75 - 
2.34) 







1.04 (0.95 - 
1.15) 
1.04 (0.95 - 
1.15) 
1.13 (0.91 - 
1.41) 
1.13 (0.91 - 
1.40) 
1.39 (0.79 - 
2.44) 
1.29 (0.73 - 
2.28) 





1.05 (0.95 - 
1.15) 
1.04 (0.95 - 
1.15) 
1.13 (0.90 - 
1.41) 
1.12 (0.90 - 
1.39) 
1.38 (0.79 - 
2.40) 
1.30 (0.75 - 
2.27) 







1.05 (0.95 - 
1.15) 
1.05 (0.95 - 
1.16) 
1.12 (0.90 - 
1.41) 
1.12 (0.90 - 
1.40) 
1.37 (0.78 - 
2.40) 
1.27 (0.72 - 
2.23) 





1.05 (0.95 - 
1.16) 
1.04 (0.95 - 
1.15) 
1.14 (0.91 - 
1.42) 
1.13 (0.91 - 
1.41) 
1.39 (0.79 - 
2.45) 
1.30 (0.74 - 
2.29) 
Compound density, 
terciles   
0.40 
1.05 (0.95 – 
1.16) 
1.05 (0.95 – 
1.16) 
1.10 (0.88 - 
1.38) 
1.10 (0.89 - 
1.38) 
1.43 (0.81 - 
2.50) 
1.32 (0.75 - 
2.33) 









..  ..  ..  ..  ..  ..  ..  




..  ..  ..  ..  ..  ..  ..  






0.02 ..  ..  ..  ..  
1.33 (0.76 - 
2.34) 
1.32 (0.75 - 
2.33) 







1.04 (0.94 - 
1.14) 
1.04 (0.94 - 
1.15) 
1.09 (0.88 - 
1.36) 
1.11 (0.89 - 
1.38) 
 -   -  
Cumulative monthly 
rainfall at survey, 
mm 
22 (23) 23 (24) 0.07 ..  ..  ..  ..  
1.39 (0.79 - 
2.44) 
1.30 (0.74 - 
2.29) 
Cumulative monthly 
rainfall at sample, 
mm 
25 (30) 32 (38) 0.19 1.04 (0.94 - 
1.15) 
1.04 (0.95 - 
1.15) 
1.13 (0.90 - 
1.41) 
1.13 (0.91 - 
1.40) 









0.42 ..  ..  ..  ..  
1.44 (0.81 – 
2.54) 
1.34 (0.76 – 
2.38) 
Sample collected 






1.05 (0.95 – 
1.16) 
1.05 (0.95 – 
1.16) 
1.12 (0.90 – 
1.40) 
1.12 (0.90 – 
1.39) 
..  ..  





1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.12 (0.90 - 
1.40) 
1.11 (0.89 - 
1.38) 
1.39 (0.79 - 
2.46) 
1.32 (0.75 - 
2.33) 
Number of household 
residents 
5.7 (2.7) 6.6 (3.4) 0.32 
1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.13 (0.90 - 
1.41) 
1.12 (0.90 - 
1.39) 
1.38 (0.78 - 
2.44) 




16 (7.3) 25 (19) 0.64 
1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.10 (0.88 - 
1.37) 
1.09 (0.88 - 
1.35) 
1.39 (0.79 - 
2.45) 





4.1 (2.5) 6.1 (5.9) 0.42 
1.04 (0.94 – 
1.15) 
1.04 (0.94 – 
1.15) 
1.11 (0.89 – 
1.37) 
1.09 (0.88 – 
1.36) 
1.40 (0.79 – 
2.46) 






1.2 (0.9) 0.33 
1.04 (0.94 - 
1.15) 
1.04 (0.94 - 
1.15) 
1.13 (0.91 - 
1.40) 
1.12 (0.90 - 
1.39) 
1.40 (0.79 - 
2.47) 







1.9 (2.4) 0.47 1.03 (0.93 - 
1.14) 
1.03 (0.93 - 
1.14) 
1.13 (0.91 - 
1.42) 
1.12 (0.90 - 
1.39) 
1.45 (0.82 - 
2.56) 
1.37 (0.77 - 
2.43) 
*Standardized difference between arms in baseline covariates. † Compared with 12-month unadjusted prevalence ratio (12-month difference-in-137 
difference estimator). ‡ Compared with 12-month prevalence ratio adjusted for a priori covariates child age, sex, caregiver education, and poverty 138 
(wealth score).  139 
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Appendix 1-table 10: Effect estimates (prevalence ratios) for main analyses and all sub-group analyses adjusted for a priori covariates 140 
and age-squared  141 
 
Main analysis, all children† 
Sub-group analysis, children born 
after intervention* 








12-month 24-month 12-month 24-month 12-month 24-month 24-month 
Any bacterial or 
protozoan infection 
1.05 (0.96 - 1.15), 
p=0.29 
1.00 (0.92 - 
1.09), p=0.97 
0.95 (0.64 - 
1.42), p=0.81 
0.97 (0.79 - 
1.18), p=0.73 
1.02 (0.91 - 
1.14), p=0.73 
0.99 (0.89 - 
1.11), p=0.89 
0.98 (0.91 - 
1.05), p=0.57 
Any STH infection 
1.16 (0.93 - 1.43), 
p=0.18 
0.94 (0.77 - 
1.15), p=0.54 
1.38 (0.35 - 
5.44), p=0.65 
0.48 (0.26 - 
0.92), p=0.026 
1.20 (0.91 - 
1.59), p=0.20 
1.22 (0.85 - 
1.75), p=0.27 
1.04 (0.83 - 
1.32), p=0.72 
Diarrhea 
1.73 (0.91 - 3.28), 
p=0.094 
0.84 (0.46 - 
1.51), p=0.55 
1.66 (0.32 - 
8.68), p=0.55 
1.32 (0.45 - 
3.90), p=0.61 
1.71 (0.79 - 
3.71), p=0.17 
0.68 (0.31 - 
1.48), p=0.33 
0.82 (0.36 - 
1.87), p=0.64 
Any Bacteria 
1.10 (0.96 - 1.26), 
p=0.15 
1.01 (0.88 - 
1.16), p=0.87 
1.23 (0.75 - 
2.02), p=0.42 
0.88 (0.66 - 
1.16), p=0.37 
1.02 (0.86 - 
1.20), p=0.85 
1.02 (0.85 - 
1.22), p=0.85 
0.96 (0.84 - 
1.11), p=0.61 
Shigella 
1.14 (0.94 - 1.38), 
p=0.18 
0.97 (0.81 - 
1.16), p=0.75 
0.87 (0.25 - 
3.02), p=0.83 
0.48 (0.28 - 
0.84), p=0.009 
1.09 (0.87 - 
1.35), p=0.47 
0.96 (0.75 - 
1.23), p=0.76 
1.02 (0.85 - 
1.23), p=0.82 
ETEC 
0.97 (0.70 - 1.35), 
p=0.86 
0.83 (0.57 - 
1.20), p=0.32 
0.80 (0.33 - 
1.95), p=0.63 
0.84 (0.47 - 
1.49), p=0.55 
0.86 (0.58 - 
1.29), p=0.47 
0.86 (0.52 - 
1.40), p=0.53 
0.75 (0.47 - 
1.20), p=0.23 
Campylobacter 
1.70 (0.83 - 3.49), 
p=0.15 
1.29 (0.63 - 
2.64), p=0.49 
2.67 (0.59 - 
12.00), p=0.2 
1.63 (0.59 - 
4.54), p=0.35 
1.51 (0.60 - 
3.76), p=0.38 
1.52 (0.60 - 
3.83), p=0.38 
0.98 (0.30 - 
3.21), p=0.97 
C. difficile 
2.06 (0.76 - 5.53), 
p=0.15 
1.38 (0.45 - 
4.20), p=0.57 
1.42 (0.43 - 
4.65), p=0.57 
1.45 (0.40 - 
5.25), p=0.57 
1.35 (0.23 - 
7.78), p=0.74 
0.23 (0.02 - 
2.67), p=0.24 
..‡ 
E. coli O157 
0.47 (0.18 - 1.23), 
p=0.13 
0.52 (0.17 - 
1.59), p=0.25 
0.00 (0.00 - 
0.01), p=0.00 
0.52 (0.07 - 
4.14), p=0.54 
0.68 (0.22 - 
2.07), p=0.50 
0.58 (0.12 - 
2.86), p=0.51 
0.48 (0.13 - 
1.78), p=0.27 
STEC 
0.15 (0.03 - 0.71), 
p=0.017 
0.24 (0.06 - 
1.03), p=0.055 
..‡ 0.05 (0.00 - 
1.26), p=0.069 
0.11 (0.01 - 
1.32), p=0.082 
0.58 (0.07 - 
5.00), p=0.62 
1.70 (0.14 - 
20.35), p=0.67 
Y. enterocolitica ..‡ ..‡ ..‡ ..‡ ..‡ ..‡ ..‡ 
V. cholerae ..‡ ..‡ ..‡ ..‡ ..‡ ..‡ ..‡ 
Any Protozoa 
1.05 (0.89 - 1.23), 
p=0.6 
0.92 (0.78 - 
1.09), p=0.34 
0.42 (0.14 - 
1.26), p=0.12 
0.86 (0.60 - 
1.23), p=0.41 
1.20 (0.97 - 
1.48), p=0.095 
0.92 (0.73 - 
1.16), p=0.49 
0.94 (0.80 - 
1.10), p=0.45 
Giardia 
1.07 (0.91 - 1.26), 
p=0.43 
0.95 (0.80 - 
1.12), p=0.51 
0.46 (0.15 - 
1.47), p=0.19 
0.89 (0.62 - 
1.28), p=0.52 
1.19 (0.96 - 
1.47), p=0.11 
0.92 (0.73 - 
1.16), p=0.47 
0.96 (0.81 - 
1.13), p=0.6 
Cryptosporidium 
0.89 (0.24 - 3.33), 
p=0.86 
0.53 (0.13 - 
2.17), p=0.38 
0.33 (0.02 - 
6.28), p=0.46 
0.51 (0.09 - 
2.78), p=0.44 
1.46 (0.21 - 
10.18), p=0.7 
0.59 (0.06 - 
5.45), p=0.64 
0.20 (0.02 - 
2.28), p=0.19 




0.75 (0.44 - 1.28), 
p=0.29 
1.03 (0.57 - 
1.86), p=0.92 
0.37 (0.14 - 
1.03), p=0.056 
0.79 (0.35 - 
1.78), p=0.57 
1.09 (0.52 - 
2.29), p=0.83 
0.95 (0.41 - 
2.19), p=0.91 
1.44 (0.61 - 
3.38), p=0.41 
Norovirus GI/GII 
0.68 (0.36 - 1.28), 
p=0.23 
1.10 (0.55 - 
2.18), p=0.79 
0.42 (0.12 - 
1.41), p=0.16 
1.25 (0.47 - 
3.29), p=0.66 
0.86 (0.37 - 
2.00), p=0.73 
0.74 (0.29 - 
1.90), p=0.53 
1.16 (0.45 - 
3.04), p=0.76 
Adenovirus 40/41 
1.26 (0.32 - 4.95), 
p=0.74 
0.96 (0.18 - 
5.20), p=0.96 
0.85 (0.09 - 
8.30), p=0.89 
..‡ 3.77 (0.48 - 
29.56), p=0.21 
6.17 (0.51 - 
75.19), p=0.15 
7.51 (0.72 - 
77.98), p=0.091 
Rotavirus A ..‡ ..‡ ..‡ ..‡ ..‡ ..‡ ..‡ 
Coinfection, ≥2 GPP 
pathogens 
1.10 (0.93 - 1.30), 
p=0.27 
0.94 (0.80 - 
1.11), p=0.49 
0.75 (0.33 - 
1.71), p=0.49 
0.83 (0.58 - 
1.17), p=0.29 
1.15 (0.93 - 
1.42), p=0.19 
0.97 (0.78 - 
1.21), p=0.81 
0.93 (0.78 - 
1.11), p=0.44 
Trichuris 
1.05 (0.83 - 1.32), 
p=0.68 
0.85 (0.67 - 
1.08), p=0.17 
0.99 (0.23 - 
4.27), p=0.98 
0.24 (0.10 - 
0.60), p=0.002 
1.11 (0.80 - 
1.52), p=0.54 
1.14 (0.76 - 
1.70), p=0.54 
0.99 (0.77 - 
1.27), p=0.92 
Ascaris 
1.38 (0.95 - 1.99), 
p=0.088 
0.83 (0.54 - 
1.26), p=0.37 
3.11 (0.30 - 
32.54), p=0.34 
0.65 (0.29 - 
1.47), p=0.3 
1.20 (0.76 - 
1.92), p=0.43 
0.86 (0.42 - 
1.75), p=0.68 
0.86 (0.51 - 
1.44), p=0.56 
Coinfection, ≥2 STH 
1.21 (0.78 - 1.85), 
p=0.39 
0.62 (0.37 - 
1.06), p=0.079 
1.76 (0.15 - 21), 
p=0.66 
0.12 (0.01 - 
1.06), p=0.057 
1.01 (0.53 - 
1.93), p=0.97 
0.70 (0.30 - 
1.62), p=0.40 
0.72 (0.40 - 
1.29), p=0.27 
All effect estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized estimating 142 
equations to fit Poisson regression models with robust standard errors. All models are adjusted for a priori covariates (age, sex, wealth, caregiver 143 
education) and age squared to assess the impact of the age squared term on effect estimates. †Results from main analyses examining intervention 144 
effects among all enrolled children at 12-month and 24-month visits. Effect estimates compared with 12-month and 24-month results in Table 2. 145 
*Results from sub-group analyses which compared children born after the intervention was implemented with children of a similar age at baseline. 146 
Effect estimates compared with results in Table 3 (24-month sub-group analysis results) and Appendix 1-table 13 (12-month sub-group analysis 147 
results). ⁑Results from sub-group analyses including children with repeated measures at baseline and the 12-month phase or baseline and the 24-148 
month phase. Effect estimates compared with results in Appendix 1-tables 14 and 15. ⁂ Results from sub-group analysis comparing children aged 149 
>2 years old at baseline and 24-month phase. Effect estimates compared with results in Appendix 1-table 12. 150 
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Appendix 1-table 11: Comparison of effect estimates (prevalence ratios) at 12- and 24 month adjusted for a priori covariates only and 151 
for a priori covariates and seasonality. 152 
 
12-month prevalence ratio (95% CI) 24-month prevalence ratio (95% CI) 
 
Adjusted (a priori only)† Adjusted + Seasonality* Adjusted (a priori only)† Adjusted + Seasonality* 
Any bacterial or protozoan 
infection 
1.04 (0.94 - 1.15), 
p=0.41 
1.05 (0.95 - 1.15), 
p=0.37 
0.99 (0.91 - 1.09), 
p=0.89 
1.00 (0.91 - 1.10), 
p=0.95 
Any STH infection 
1.11 (0.89 - 1.38), 
p=0.35 
1.12 (0.90 - 1.39), 
p=0.31 
0.95 (0.77 - 1.17), 
p=0.62 
0.94 (0.76 - 1.15), 
p=0.54 
Diarrhea 
1.69 (0.89 - 3.21), 
p=0.11 
1.67 (0.88 - 3.17), 
p=0.12 
0.84 (0.47 - 1.51), 
p=0.56 
0.81 (0.44 - 1.46), 
p=0.48 
Any Bacteria 
1.09 (0.95 - 1.26), 
p=0.20 
1.10 (0.96 - 1.26), 
p=0.18 
1.00 (0.87 - 1.15), 
p=0.95 
1.03 (0.89 - 1.18), 
p=0.71 
Shigella 
1.12 (0.92 - 1.38), 
p=0.27 
1.12 (0.91 - 1.37), 
p=0.28 
0.95 (0.79 - 1.16), 
p=0.64 
0.97 (0.80 - 1.17), 
p=0.72 
ETEC 
0.96 (0.69 - 1.33), 
p=0.81 
0.98 (0.70 - 1.35), 
p=0.89 
0.83 (0.57 - 1.19), 
p=0.31 
0.88 (0.61 - 1.26), 
p=0.47 
Campylobacter 
1.68 (0.82 - 3.45), 
p=0.16 
1.72 (0.84 - 3.49), 
p=0.14 
1.28 (0.62 - 2.62), p=0.5 
1.33 (0.65 - 2.71), 
p=0.43 
C. difficile 
2.09 (0.77 - 5.64), 
p=0.15 
2.17 (0.81 - 5.86), 
p=0.13 
1.41 (0.46 - 4.30), 
p=0.54 
1.44 (0.48 - 4.37), 
p=0.52 
E. coli O157 
0.46 (0.18 - 1.21), 
p=0.12 
0.48 (0.18 - 1.26), 
p=0.14 
0.52 (0.17 - 1.59), 
p=0.25 
0.57 (0.19 - 1.74), 
p=0.32 
STEC 
0.15 (0.03 - 0.70), 
p=0.016 
0.15 (0.03 - 0.74), 
p=0.019 
0.24 (0.05 - 1.01), 
p=0.052 
0.25 (0.06 - 1.06), 
p=0.061 
Y. enterocolitica ..‡ ..‡ ..‡ ..‡ 
V. cholerae ..‡ ..‡ ..‡ ..‡ 
Any Protozoa 
1.03 (0.86 - 1.22), 
p=0.76 
1.03 (0.87 - 1.23), 
p=0.72 
0.91 (0.76 - 1.09), 
p=0.29 
0.91 (0.76 - 1.09), 
p=0.31 
Giardia 
1.05 (0.88 - 1.25), 
p=0.58 
1.06 (0.88 - 1.26), 
p=0.54 
0.93 (0.78 - 1.11), 
p=0.43 
0.93 (0.78 - 1.12), 
p=0.45 
Cryptosporidium 
0.89 (0.24 - 3.31), 
p=0.86 
0.83 (0.22 - 3.11), 
p=0.78 
0.53 (0.13 - 2.14), 
p=0.37 
0.46 (0.12 - 1.73), 
p=0.25 




0.75 (0.44 - 1.27), 
p=0.29 
0.74 (0.43 - 1.26), 
p=0.26 
1.03 (0.57 - 1.86), 
p=0.92 
0.97 (0.54 - 1.75), 
p=0.91 
Norovirus GI/GII 
0.68 (0.36 - 1.27), 
p=0.23 
0.67 (0.35 - 1.27), 
p=0.22 
1.10 (0.55 - 2.18), 
p=0.79 
1.04 (0.53 - 2.07), 
p=0.90 
Adenovirus 40/41 
1.24 (0.32 - 4.83), 
p=0.76 
1.29 (0.33 - 5.13), 
p=0.71 
0.97 (0.18 - 5.19), 
p=0.97 
1.01 (0.19 - 5.30), 
p=0.99 
Rotavirus ..‡ ..‡ ..‡ ..‡ 
Coinfection, ≥2 GPP pathogens 
1.08 (0.91 - 1.29), 
p=0.37 
1.09 (0.91 - 1.30), 
p=0.35 
0.93 (0.79 - 1.10), 
p=0.41 
0.94 (0.79 - 1.12), 
p=0.49 
Trichuris 
1.01 (0.79 - 1.28), 
p=0.96 
1.02 (0.81 - 1.30), 
p=0.86 
0.86 (0.67 - 1.10), 
p=0.22 
0.85 (0.67 - 1.09), 
p=0.21 
Ascaris 
1.33 (0.92 - 1.93), 
p=0.13 
1.35 (0.93 - 1.95), 
p=0.11 
0.83 (0.54 - 1.27), 
p=0.39 
0.81 (0.53 - 1.25), 
p=0.34 
Coinfection, ≥2 STH 
1.17 (0.76 - 1.79), 
p=0.49 
1.20 (0.78 - 1.83), 
p=0.40 
0.63 (0.37 - 1.07), 
p=0.084 
0.62 (0.36 - 1.06), 
p=0.079 
All effect estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized 153 
estimating equations to fit Poisson regression models with robust standard errors. †Models are adjusted for a priori covariates age, 154 
sex, caregiver’s education, and wealth and presented for comparison with seasonality-adjusted models. *Models are adjusted for a 155 
priori covariates and seasonality using sine/cosine terms based on the date of sample (or survey) collection. 156 
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Appendix 1-table 12: Effect of the intervention on enteric infection and diarrhea in children >2 years old after 24 months 157 
 
Prevalence Prevalence ratio (95% CI), p-value 
 
Baseline, aged >2 years 24-month, aged >2 years unadjusted adjusted† 
Any bacterial or protozoan 
infection‡     
Control 155/164 (95%) 315/340 (93%) .. .. 
Intervention 149/160 (93%) 312/344 (91%) 0.99 (0.93 - 1.07), p=0.86 0.98 (0.91 - 1.05), p=0.60 
Any STH infection‡   
  
Control 103/155 (66%) 113/175 (65%) .. .. 
Intervention 86/146 (59%) 121/208 (58%) 1.03 (0.82 - 1.30), p=0.79 1.05 (0.83 - 1.32), p=0.69 
Diarrhea‡   
  
Control 21/243 (8.6%) 33/273 (12%) .. .. 
Intervention 16/210 (7.6%) 31/303 (10%) 0.96 (0.45 - 2.07), p=0.93 0.82 (0.36 - 1.86), p=0.63 
Any Bacteria   
  
Control 129/164 (79%) 267/340 (79%) .. .. 
Intervention 125/160 (78%) 266/344 (77%) 1.00 (0.87 - 1.15), p=0.98 0.97 (0.84 - 1.11), p=0.64 
Shigella   
  
Control 112/164 (68%) 227/340 (67%) .. .. 
Intervention 103/160 (64%) 223/344 (65%) 1.05 (0.87 - 1.26), p=0.63 1.03 (0.85 - 1.24), p=0.79 
ETEC     
Control 46/164 (28%) 93/340 (27%) .. .. 
Intervention 52/160 (33%) 100/344 (29%) 0.88 (0.56 - 1.38), p=0.58 0.74 (0.46 - 1.20), p=0.22 
Campylobacter   
  
Control 12/164 (7.3%) 33/340 (9.7%) .. .. 
Intervention 7/160 (4.4%) 20/344 (5.8%) 0.97 (0.33 - 2.90), p=0.96 1.00 (0.30 - 3.28), p=0.99 
C. difficile     
Control 2/164 (1.2%) 6/340 (1.8%) .. .. 
Intervention 0/160 (0.0%) 4/344 (1.2%) ..‡ ..‡ 
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E. coli O157   
  
Control 6/164 (3.7%) 21/340 (6.2%) .. .. 
Intervention 9/160 (5.6%) 13/344 (3.8%) 0.39 (0.11 - 1.40), p=0.15 0.47 (0.13 - 1.78), p=0.27 
STEC     
Control 2/164 (1.2%) 15/340 (4.4%) .. .. 
Intervention 1/160 (0.63%) 13/344 (3.8%) 1.54 (0.12 - 19.19), p=0.74 1.73 (0.14 - 20.75), p=0.67 
Y. enterocolitica     
Control 0/164 (0.0%) 0/340 (0.0%) .. .. 
Intervention 0/160 (0.0%) 1/344 (0.29%) ..‡ ..‡ 
V. cholerae     
Control 0/164 (0.0%) 0/340 (0.0%) .. .. 
Intervention 0/160 (0.0%) 0/344 (0.0%) ..‡ ..‡ 
Any Protozoa   
  
Control 123/164 (75%) 250/340 (74%) .. .. 
Intervention 121/160 (76%) 245/344 (71%) 0.96 (0.82 - 1.13), p=0.66 0.94 (0.80 - 1.11), p=0.47 
Giardia     
Control 122/164 (74%) 244/340 (72%) .. .. 
Intervention 118/160 (74%) 240/344 (70%) 0.99 (0.84 - 1.16), p=0.86 0.96 (0.81 - 1.13), p=0.62 
Cryptosporidium     
Control 1/164 (0.61%) 9/340 (2.6%) .. .. 
Intervention 4/160 (2.5%) 8/344 (2.3%) 0.20 (0.02 - 2.27), p=0.19 0.21 (0.02 - 2.46), p=0.21 
E. histolytica     
Control 0/164 (0.0%) 2/340 (0.59%) .. .. 
Intervention 3/160 (1.9%) 10/344 (2.9%) ..‡ ..‡ 
Any virus     
Control 19/164 (12%) 39/340 (11%) .. .. 
Intervention 16/160 (10%) 43/344 (13%) 1.24 (0.55 - 2.78), p=0.6 1.44 (0.61 - 3.38), p=0.41 




Control 12/164 (7.3%) 34/340 (10%) .. .. 
Intervention 13/160 (8.1%) 37/344 (11%) 0.96 (0.39 - 2.34), p=0.92 1.17 (0.45 - 3.03), p=0.75 
Adenovirus 40/41     
Control 6/164 (3.7%) 2/340 (0.59%) .. .. 
Intervention 2/160 (1.3%) 6/344 (1.7%) 11 (0.97 – 119), p=0.053 7.5 (0.72 – 79), p=0.92 
Rotavirus A     
Control 1/164 (0.61%) 3/340 (0.88%) .. .. 
Intervention 1/160 (0.63%) 1/344 (0.29%) ..‡ ..‡ 
Coinfection, ≥2 GPP pathogens     
Control 114/164 (70%) 243/340 (71%) .. .. 
Intervention 111/160 (69%) 236/344 (69%) 0.97 (0.82 - 1.15), p=0.71 0.93 (0.78 - 1.12), p=0.45 
Trichuris     
Control 91/155 (59%) 102/175 (58%) .. .. 
Intervention 76/146 (52%) 110/208 (53%) 1.04 (0.81 - 1.33), p=0.78 0.99 (0.77 - 1.27), p=0.96 
Ascaris     
Control 50/155 (32%) 61/175 (35%) .. .. 
Intervention 39/146 (27%) 47/208 (23%) 0.78 (0.47 - 1.29), p=0.33 0.86 (0.51 - 1.44), p=0.57 
Coinfection, ≥2 STH     
Control 38/155 (25%) 50/175 (29%) .. .. 
Intervention 29/146 (20%) 36/208 (17%) 0.74 (0.42 - 1.28), p=0.28 0.72 (0.41 – 1.29), p=0.27 
Analysis includes children <2 year old at baseline or the 24-month visit. Prevalence results are presented as (n/N (%)). All effect estimates are 158 
presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized estimating equations to fit Poisson 159 
regression models with robust standard errors. †Pathogen outcomes adjusted for child age and sex, caregiver’s education, and household wealth 160 
index, reported diarrhea also adjusted for baseline presence of a drop-hole cover and reported use of a tap on compound grounds as primary 161 




Appendix 1-table 13: Effect of intervention on enteric infection and reported diarrhea in children born into study sites post 164 
implementation (post-baseline) and before 12-month visit compared with children of a similar age at baseline (<1 year old).  165 
 
Prevalence Prevalence ratio 
 
Baseline, children 
<1 year old 
12-month, children 
born-in & <1 year old 
unadjusted adjusted† 
Any bacterial or protozoan infection 
    
Control 57/109 (52%) 31/48 (65%) .. .. 
Intervention 51/99 (52%) 
32/55 (58%) 
0.89 (0.60 - 1.33), 
p=0.58 
0.97 (0.65 - 1.45), 
p=0.90 
Any STH infection 
    
Control 17/93 (18%) 3/25 (12%) .. .. 
Intervention 13/92 (14%) 4/32 (13%) 
1.31 (0.32 - 5.42), 
p=0.71 
1.38 (0.35 - 5.45), 
p=0.65 
Diarrhea 
    
Control 19/138 (14%) 6/50 (12%) .. .. 
Intervention 18/120 (15%) 13/69 (19%) 
1.38 (0.47 - 4.01), 
p=0.56 
1.80 (0.35 - 9.31), 
p=0.48 
Any Bacteria 
    
Control 53/109 (49%) 24/48 (50%) .. .. 
Intervention 41/99 (41%) 
29/55 (53%) 
1.22 (0.75 - 1.98), 
p=0.43 
1.28 (0.78 - 2.10), 
p=0.33 
Shigella 
    
Control 10/109 (9.2%) 9/48 (19%) .. .. 
Intervention 9/99 (9.1%) 
9/55 (16%) 
0.87 (0.26 - 2.91), 
p=0.82 





Control 25/109 (23%) 12/48 (25%) .. .. 
Intervention 22/99 (22%) 
11/55 (20%) 
0.82 (0.34 - 1.99), 
p=0.66 
0.80 (0.33 - 1.92), 
p=0.62 
Campylobacter 
    
Control 14/109 (13%) 4/48 (8.3%) .. .. 








Control 13/109 (12%) 7/48 (15%) .. .. 
Intervention 10/99 (10%) 
9/55 (16%) 
1.37 (0.42 - 4.45), 
p=0.60 
1.49 (0.46 - 4.89), 
p=0.51 
E. coli O157 
    
Control 4/109 (3.7%) 1/48 (2.1%) .. .. 
Intervention 2/99 (2%) 0/55 (0.0%) 




    
Control 0/109 (0.0%) 0/48 (0.0%) .. .. 




Control 0/109 (0.0%) 0/48 (0.0%) .. .. 
Intervention 0/99 (0.0%) 0/55 (0.0%) ..‡ ..‡ 
V. cholerae 
    
Control 0/109 (0.0%) 0/48 (0.0%) .. .. 
Intervention 0/99 (0.0%) 0/55 (0.0%) ..‡ ..‡ 
Any Protozoa 
    
Control 14/109 (13%) 15/48 (31%) .. .. 
Intervention 22/99 (22%) 9/55 (16%) 
0.35 (0.12 - 1.02), 
p=0.055 
0.40 (0.13 – 1.20), 
p=0.10 
Giardia 
    
Control 12/109 (11%) 13/48 (27%) .. .. 
Intervention 16/99 (16%) 
8/55 (15%) 
0.41 (0.13 - 1.24), 
p=0.11 






Control 2/109 (1.8%) 2/48 (4.2%) .. .. 
Intervention 8/99 (8.1%) 
2/55 (3.6%) 
0.25 (0.02 - 3.70), 
p=0.31 
0.40 (0.02 – 7.9), 
p=0.55 
E. histolytica 
    
Control 0/109 (0.0%) 1/48 (2.1%) .. .. 
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Intervention 1/99 (1%) 0/55 (0.0%) ..‡ ..‡ 
Any virus 
    
Control 15/109 (14%) 12/48 (25%) .. .. 
Intervention 21/99 (21%) 7/55 (13%) 
0.33 (0.12 - 0.92), 
p=0.033 






Control 12/109 (11%) 9/48 (19%) .. .. 
Intervention 15/99 (15%) 
6/55 (11%) 
0.43 (0.13 - 1.40), 
p=0.16 
0.44 (0.13 – 1.47), 
p=0.18 
Adenovirus 40/41 
    
Control 4/109 (3.7%) 4/48 (8.3%) .. .. 
Intervention 3/99 (3%) 2/55 (3.6%) 
0.56 (0.06 - 5.05), 
p=0.61 






Control 0/109 (0.0%) 0/48 (0.0%) .. .. 
Intervention 3/99 (3%) 0/55 (0.0%) ..‡ ..‡ 
Coinfection, ≥2 GPP pathogens     
Control 23/109 (21%) 16/48 (33%) .. .. 
Intervention 25/99 (25%) 
15/55 (27%) 
0.73 (0.31 - 1.71), 
p=0.47 
0.74 (0.33 – 1.69), 
p=0.48 
Trichuris 
    
Control 10/93 (11%) 3/25 (12%) .. .. 
Intervention 10/92 (11%) 4/32 (13%) 
1.04 (0.21 - 5.01), 
p=0.96 
 
0.98 (0.23 - 4.29), 
p=0.98 
Ascaris 
    
Control 12/93 (13%) 1/25 (4%) .. .. 
Intervention 9/92 (9.8%) 3/32 (9.4%) 
2.87 (0.30 - 27.85), 
p=0.36 
3.10 (0.30 – 32.5), 
p=0.35 




Control 5/93 (5.4%) 1/25 (4%) .. .. 




Analysis includes children <1 year old at baseline and children born into the study after baseline and <1 year old at the time of the 12-month visit. 166 
Prevalence results are presented as (n/N (%)). All effect estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals 167 
and estimated using generalized estimating equations to fit Poisson regression models with robust standard errors. †Pathogen outcomes adjusted 168 
for child age and sex, caregiver’s education, and household wealth index, reported diarrhea also adjusted for baseline presence of a drop-hole 169 
cover and reported use of a tap on compound grounds as primary drinking water source. ‡ Models did not converge due to sparse data.  170 
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Appendix 1-table 14: Effect of the intervention on children with repeated observations at baseline and 12-month visit.  171 
 
Prevalence Prevalence ratio 
 
Baseline 12-month unadjusted adjusted† 
Any bacterial or protozoan 
infection     
Control 161/207 (78%) 187/207 (90%) .. .. 
Intervention 174/228 (76%) 207/228 (91%) 1.02 (0.91 - 1.16), p=0.70 1.01 (0.90 - 1.14), p=0.84 
Any STH infection 
    
Control 67/132 (51%) 80/132 (61%) .. .. 
Intervention 63/154 (41%) 91/154 (59%) 1.22 (0.92 - 1.61), p=0.17 1.16 (0.87 - 1.55), p=0.31 
Diarrhea 
    
Control 36/277 (13%) 17/277 (6.1%) .. .. 
Intervention 42/279 (15%) 34/279 (12%) 1.71 (0.78 - 3.77), p=0.18 1.71 (0.79 - 3.70), p=0.17 
Any Bacteria 
    
Control 141/207 (68%) 165/207 (80%) .. .. 
Intervention 142/228 (62%) 170/228 (75%) 1.02 (0.86 - 1.22), p=0.8 1.01 (0.85 - 1.20), p=0.92 
Shigella 
    
Control 89/207 (43%) 128/207 (62%)   
Intervention 90/228 (39%) 142/228 (62%) 1.10 (0.86 - 1.39), p=0.45 1.08 (0.85 - 1.37), p=0.54 
ETEC 
    
Control 63/207 (30%) 83/207 (40%)   
Intervention 71/228 (31%) 79/228 (35%) 0.84 (0.56 - 1.27), p=0.41 0.85 (0.57 - 1.28), p=0.44 
Campylobacter 
    
Control 20/207 (9.7%) 18/207 (8.7%)   
Intervention 13/228 (5.7%) 18/228 (7.9%) 1.54 (0.62 - 3.80), p=0.35 1.49 (0.60 - 3.71), p=0.39 
C. difficile 
    
Control 15/207 (7.3%) 4/207 (1.9%)   
Intervention 8/228 (3.5%) 3/228 (1.3%) 1.39 (0.24 - 8.00), p=0.71 1.45 (0.25 - 8.52), p=0.68 
E. coli O157 
    
42 
 
Control 9/207 (4.3%) 15/207 (7.3%) .. .. 
Intervention 9/228 (4.0%) 10/228 (4.4%) 0.67 (0.22 - 2.03), p=0.48 0.68 (0.22 - 2.06), p=0.49 
STEC 
    
Control 1/207 (0.48%) 6/207 (2.9%) .. .. 
Intervention 6/228 (2.6%) 4/227 (1.8%) 0.11 (0.01 - 1.31), p=0.081 0.11 (0.01 - 1.32), p=0.082 
Y. enterocolitica 
    
Control 0/207 (0.0%) 0/207 (0.0%) .. .. 
Intervention 1/228 (0.44%) 0/227 (0.0%) ..‡ ..‡ 
V. cholerae 
    
Control 0/207 (0.0%) 0/207 (0.0%) .. .. 
Intervention 0/228 (0.0%) 0/227 (0.0%) ..‡ ..‡ 
Any Protozoa 
    
Control 109/207 (53%) 130/207 (63%) .. .. 
Intervention 117/228 (51%) 166/228 (73%) 1.19 (0.95 - 1.48), p=0.13 1.18 (0.94 - 1.47), p=0.15 
Giardia 
    
Control 106/207 (51%) 130/207 (63%)   
Intervention 113/228 (50%) 164/228 (72%) 1.18 (0.94 - 1.48), p=0.15 1.17 (0.93 - 1.47), p=0.17 
Cryptosporidium 
    
Control 6/207 (2.9%) 2/207 (0.97%) .. .. 
Intervention 10/228 (4.4%) 5/227 (2.2%) 1.44 (0.21 - 9.82), p=0.71 1.45 (0.22 - 9.71), p=0.7 
E. histolytica 
    
Control 0/207 (0.0%) 0/207 (0.0) .. .. 
Intervention 2/228 (0.88%) 7/228 (3.1%) ..‡ ..‡ 
Any virus 
    
Control 27/207 (13%) 20/207 (9.7%) .. .. 
Intervention 31/228 (14%) 25/228 (11%) 1.05 (0.50 - 2.22), p=0.89 1.08 (0.51 - 2.26), p=0.84 
Norovirus GI/GII 
    
Control 20/207 (9.7%) 19/207 (9.2%)   
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Intervention 23/228 (11%) 19/228 (8.3%) 0.83 (0.36 - 1.94), p=0.67 0.86 (0.37 - 1.99), p=0.72 
Adenovirus 40/41 
    
Control 7/207 (3.4%) 2/207 (0.97%) .. .. 
Intervention 6/228 (2.6%) 6/228 (2.6%) 3.56 (0.46 - 27.24), p=0.22 3.59 (0.46 - 27.91), p=0.22 
Rotavirus A 
    
Control 1/207 (0.48%) 1/207 (0.48%) .. .. 
Intervention 4/228 (1.8%) 1/228 (0.44%) ..‡ ..‡ 
Coinfection, ≥2 GPP pathogens     
Control 114/207 (55%) 135/207 (65%) .. .. 
Intervention 115/228 (50%) 156/228 (68%) 1.15 (0.92 - 1.43), p=0.23 1.14 (0.91 - 1.42), p=0.25 
Trichuris 
    
Control 49/132 (37%) 64/132 (48%) .. .. 
Intervention 53/154 (34%) 77/154 (50%) 1.12 (0.81 - 1.54), p=0.50 1.06 (0.76 - 1.48), p=0.72 
Ascaris 
    
Control 40/132 (30%) 46/132 (35%)   
Intervention 35/154 (23%) 49/154 (32%) 1.22 (0.77 - 1.93), p=0.4 1.17 (0.73 - 1.86), p=0.51 
Coinfection, ≥2 STH 
  
  Control 22/132 (17%) 30/132 (23%) .. .. 
Intervention 25/154 (16%) 35/154 (23%) 1.03 (0.55 - 1.93), p=0.94 0.97 (0.51 - 1.85), p=0.93 
Analysis includes children with complete observations at baseline and 12-month visits. Prevalence results are presented as (n/N (%)). All effect 172 
estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized estimating equations to 173 
fit Poisson regression models with robust standard errors. †Pathogen outcomes adjusted for child age and sex, caregiver’s education, and 174 
household wealth index, reported diarrhea also adjusted for baseline presence of a drop-hole cover and reported use of a tap on compound grounds 175 
as primary drinking water source. ‡ Models would not converge due to sparse data.  176 
  177 
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Appendix 1-table 15: Effect of the intervention on children with repeated observations at baseline and 24-month visit.  178 
 
Prevalence Prevalence ratio 
 
Baseline 24-month unadjusted adjusted† 
Any bacterial or protozoan infection 
    
Control 131/166 (79%) 155/166 (93%) .. .. 
Intervention 151/192 (79%) 175/192 (91%) 0.98 (0.87 - 1.10), p=0.73 0.98 (0.87 - 1.10), p=0.70 
Any STH infection 
    
Control 48/95 (51%) 65/95 (68%) .. .. 
Intervention 38/106 (36%) 62/106 (58%) 1.20 (0.84 - 1.70), p=0.31 1.25 (0.87 - 1.78), p=0.23 
Diarrhea 
    
Control 25/196 (13%) 20/196 (10%) .. .. 
Intervention 34/221 (15%) 20/221 (9.1%) 0.72 (0.33 - 1.58), p=0.41 0.69 (0.31 - 1.50), p=0.35 
Any Bacteria 
    
Control 109/166 (66%) 138/166 (83%) .. .. 




Control 66/166 (40%) 121/166 (73%)   
Intervention 79/192 (41%) 136/192 (71%) 0.93 (0.71 - 1.22), p=0.60 0.93 (0.71 - 1.22), p=0.60 
ETEC 
    
Control 47/166 (28%) 47/166 (28%)   
Intervention 58/192 (30%) 52/192 (27%) 0.90 (0.55 - 1.46), p=0.66 0.85 (0.52 - 1.39), p=0.52 
Campylobacter 
    
Control 16/166 (9.6%) 12/166 (7.2%)   
Intervention 13/192 (6.8%) 14/192 (7.3%) 1.44 (0.56 - 3.72), p=0.45 1.52 (0.60 - 3.83), p=0.37 
C. difficile 
    
Control 9/166 (5.4%) 4/166 (2.4%) .. .. 
Intervention 8/192 (4.2%) 1/192 (0.52%) 0.28 (0.03 - 2.95), p=0.29 0.26 (0.03 - 2.59), p=0.25 
E. coli O157 
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Control 7/166 (4.2%) 9/166 (5.4%) .. .. 
Intervention 9/192 (4.7%) 8/192 (4.2%) 0.69 (0.14 - 3.40), p=0.65 0.59 (0.12 - 2.93), p=0.52 
STEC 
    
Control 2/166 (1.2%) 7/166 (4.2%) .. .. 
Intervention 3/192 (1.6%) 7/192 (3.6%) 0.66 (0.07 - 6.20), p=0.72 0.58 (0.07 - 4.89), p=0.61 
Y. enterocolitica 
    
Control 0/166 (0.0%) 0/166 (0.0%) .. .. 
Intervention 0/192 (0.0%) 1/192 (0.52%) ..‡ ..‡ 
V. cholerae 
    
Control 0/166 (0.0%) 0/166 (0.0%) .. .. 
Intervention 0/192 (0.0%) 0/192 (0.0%) ..‡ ..‡ 
Any Protozoa 
    
Control 89/166 (54%) 121/166 (73%) .. .. 
Intervention 109/192 (57%) 138/192 (72%) 0.93 (0.73 - 1.19), p=0.56 0.90 (0.69 - 1.15), p=0.39 
Giardia 
    
Control 86/166 (52%) 120/166 (72%)   
Intervention 104/192 (54%) 135/192 (70%) 0.93 (0.73 - 1.18), p=0.55 0.89 (0.69 - 1.15), p=0.38 
Cryptosporidium 
    
Control 5/166 (3%) 3/166 (1.8%) .. .. 
Intervention 11/192 (5.7%) 4/192 (2.1%) 0.57 (0.06 - 5.38), p=0.62 0.55 (0.06 - 4.93), p=0.59 
E. histolytica 
    
Control 0/166 (0.0%) 0/166 (0.0%) .. .. 
Intervention 2/192 (1%) 8/192 (4.2%) ..‡ ..‡ 
Any virus 
    
Control 21/166 (13%) 18/166 (11%) .. .. 
Intervention 30/192 (16%) 22/192 (11%) 0.86 (0.37 - 1.97), p=0.72 0.95 (0.41 - 2.19), p=0.91 
Norovirus GI/GII 
    
Control 15/166 (9%) 15/166 (9%) .. .. 
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Intervention 26/192 (14%) 17/192 (8.8%) 0.65 (0.25 - 1.69), p=0.38 0.74 (0.28 - 1.90), p=0.53 
Adenovirus 40/41 
    
Control 6/166 (3.6%) 1/166 (0.6%)   
Intervention 5/192 (2.6%) 5/192 (2.6%) 6.12 (0.48 - 78.34), p=0.16 6.01 (0.49 - 73.94), p=0.16 
Rotavirus A 
    
Control 1/166 (0.6%) 2/166 (1.2%) .. .. 
Intervention 1/192 (0.52%) 1/192 (0.52%) ..‡ ..‡ 
Coinfection, ≥2 GPP pathogens 
    
Control 89/166 (54%) 120/166 (72%) .. .. 
Intervention 102/192 (53%) 132/192 (69%) 0.96 (0.77 - 1.19), p=0.69 0.95 (0.76 - 1.19), p=0.67 
Trichuris 
    
Control 39/95 (41%) 62/95 (65%) .. .. 
Intervention 32/106 (30%) 57/106 (54%) 1.11 (0.74 - 1.67), p=0.60 1.16 (0.77 - 1.75), p=0.47 
Ascaris 
    
Control 27/95 (28%) 34/95 (36%)   
Intervention 19/106 (18%) 21/106 (20%) 0.88 (0.43 - 1.79), p=0.72 0.89 (0.44 - 1.79), p=0.74 
Coinfection, ≥2 STH 
    
Control 18/95 (19%) 31/95 (33%) .. .. 
Intervention 13/106 (12%) 16/106 (15%) 0.71 (0.30 - 1.70), p=0.44 0.72 (0.31 - 1.69), p=0.46 
Analysis includes children with complete observations at baseline and 24-month visits. Prevalence results are presented as (n/N (%)). All effect 179 
estimates are presented as prevalence ratios (ratio of ratios) with 95% confidence intervals and estimated using generalized estimating equations to 180 
fit Poisson regression models with robust standard errors. †Pathogen outcomes adjusted for child age and sex, caregiver’s education, and 181 
household wealth index, reported diarrhea also adjusted for baseline presence of a drop-hole cover and reported use of a tap on compound grounds 182 





Appendix 1-figure 5: Schematic of communal sanitation block design from the NGO (Water and 186 
Sanitation for the Urban Poor). Pictured: 2 latrine stalls, 2 pour-flush toilets, septic tank, elevated 187 
water storage tank, laundry basin, door. Not pictured: soakaway pit. Source: Water and 188 
Sanitation for the Urban Poor. 189 
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Appendix 1-figure 6: Construction of a soakaway pit for discharge of liquid effluent from 190 
intervention latrines. 191 
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Appendix 1-figure 7: Photo of communal sanitation block as constructed.192 
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Appendix 1-figure 8: Photo of shared latrine as constructed. 193 
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n=1001   
 





    
  
Enteric infection outcome data 
available 
24 14 8.0 
Binary; 0/1 Based on collection of stool material and successful 
analysis by GPP 
STH infection outcome data 
available 
30 37 46 
Binary; 0/1 Based on collection of stool material and successful 
analysis by Kato-Katz 
Caregiver-reported diarrhea, 7-
day recall 
1.3 7.8 20 
Binary; 0/1 Child Survey 
Covariate data 
   
  
Child sex, female 





Respondent is child's mother 2.5 7.6 20 Binary; 0/1 Child Survey 
Caregiver completed primary 
school 
0.8 1.7 6.7 
Binary; 0/1 Child Survey 
Child breast feeds with or 
without complementary 
feeding 
1.3 7.7 20 
Binary; 0/1 Child Survey 
Child exclusively breastfeeds 1.3 7.7 20 Binary; 0/1 Child Survey 
Child wears a diaper 1.4 7.6 20 Binary; 0/1 Child Survey 
Child feces is disposed of in a 
latrine 
1.3 7.1 20 
Binary; 0/1 Created from survey questions in Child Survey 
Child age at sampling, days 
23 16 17 
Integer Created from birthdate (Child Survey) and date of 
sampling 
Child age at survey, days 
2.6 7.5 19 
Integer Created from birthdate (Child Survey) and date of 
Survey 
30-day cumulative rainfall at 
sampling 21 14 10 
Continuous Created from sample date and data from data from 
the National Oceanic and Atmospheric 






30-day cumulative rainfall at 
survey 
1.3 7.1 19 
Continuous Created from survey date and data from data from 
the National Oceanic and Atmospheric 




Sample collection during rainy 
season 
21 14 10 
Binary; 0/1 Created from sample date. Rainy season defined as 
November – April. 
Survey collection during rainy 
season 
1.3 7.1 19 
Binary; 0/1 Created from survey date. Rainy season defined as 
November – April. 
Household crowding, >3 
persons/room 
0.4 0.3 2.7 
Binary; 0/1 Created from questions in Household Survey 
Household floor is covered 0.4 0.3 2.7 Binary; 0/1 Observation 
Household walls made of 
concrete, bricks or similar 
0.4 0.3 2.7 
Binary; 0/1 Observation 
Household population 0.3 0.3 1.6 Integer Household survey 
Number of rooms in household 0.4 0.3 2.3 Integer Created from questions in Household Survey 
Wealth score, 0 (poorest) - 1 
(wealthiest), unitless 
0.4 0.3 2.7 
Continuous Created from questions in Household Survey using 
Simple Poverty Scorecard for Mozambique 
(http://www.simplepovertyscorecard.com/MOZ_20
08_ENG.pdf). Questions referencing latrine 
removed from 12-month and 24-month score. All 
scores normalized by total number of points 
available.  
Household uses tap in 
compound as primary drinking 
water source  
1.7 1.0 2.0 
Binary 0/1 Created from drinking water source question in 
Household Survey 
Latrine has drop-hole cover 1.9 0.0 0.0 Binary; 0/1 Observation 
Latrine has a ventpipe 1.8 0.0 0.0 Binary; 0/1 Observation 
Latrine has a ceramic, tile, or 
concrete pedestal or slab 
2.2 0.1 0.1 
Binary; 0/1 Observation 
Latrine has sturdy walls made 1.9 0.0 0.0 Binary; 0/1 Observation 
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of concrete, bricks, or similar.  
Compound population 0.0 0.0 0.0 Integer Compound Survey, enrollment checklists 
Number of households in 
compound 
0.0 0.0 0.0 
Integer Compound Survey, enrollment checklists 
Number of latrines present in 
the compound 
0.1 0.0 0.0 
Integer Compound Survey 
Persons per latrine 
1.8 0.1 0.3 
Continuous Created by dividing the compound population by 
the number of latrines/drop-holes 
Households per latrine 
1.8 0.1 0.3 
Continuous Created by dividing the number of households in 
the compound by the number of latrines in the 
compound 
Number of water taps present 
in the compound 
1.1 0.0 0.0 
Integer Compound Survey 
Standing water visible around 
compound grounds 
1.9 0.3 0.0 
Binary; 0/1 Observation 
Standing or leaking wastewater 
visible around compound 
grounds 
1.9 0.3 0.0 
Binary; 0/1 Observation 
Faeces or used diapers 
observed around compound 
grounds or in solid waste 
1.9 0.3 0.0 
Binary; 0/1 Observation 
Compound floods when it rains 0.0 0.0 0.0 Binary; 0/1 Compound Survey 
Compound has electricity that 
normally functions 
0.0 0.0 0.0 
Binary; 0/1 Compound Survey 
Compound-level population 
density 
2.2 1.5 1.5 
Continuous, 
persons/m2 
Created by dividing the population of the 
compound by the measured area of the compound 
Any animal present in the 
compound 
0.0 0.4 0.0 
Binary; 0/1 Observation 
Dog(s) present in the 
compound 
0.0 0.4 0.0 
Binary; 0/1 Observation 
Chicken(s) and/or duck(s) 
present in the compound 
0.0 0.4 0.0 
Binary; 0/1 Observation 
Cat(s) present in the compound 0.0 0.4 0.0 Binary; 0/1 Observation 
Any other animal(s) present in 
the compound 
0.0 0.4 0.0 
Binary; 0/1 Observation 
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